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I 
Podocytes are specialized epithelial cells in the kidney glomerulus that play important 
structural and functional roles in maintaining the filtration barrier.  In nephrotic syndrome, a 
major breakdown of the kidney filtration barrier associated with proteinuria, hyperlipidemia, and 
edema, podocytes undergo changes in morphology and appear to internalize serum proteins.  We 
postulated that fluid-phase uptake by podocytes might play a role in maintaining the integrity of 
the filtration barrier.  Using fluid-phase tracers, we show that podocytes in vivo actively 
internalize fluid from the serum and that the rate of internalization is enhanced when the 
filtration barrier is disrupted.  In vitro experiments demonstrated that lipids associated with 
serum albumin stimulate macropinocytosis in podocytes.  This process was specific to podocytes 
as known stimuli that induce macropinocytosis in other cells had no effect on podocytes, while 
xiv 
 
serum lipids did not stimulate macropinocytosis in other cells.  A candidate lipid approach 
showed that certain unsaturated free fatty acids stimulate macropinocytosis through G protein 
coupled receptors, FFAR1, FFAR2 and FFAR3 and the Gβ/Gγ complex.  Meanwhile, long-chain 
fatty acids were found to induce apoptosis in podocytes.  These results suggest that podocytes 
sense the disruption of the filtration barrier via free fatty acids carried by albumin and respond to 
the increased protein by enhancing fluid-phase uptake.  However, alterations in free fatty acids to 
albumin ratio during nephrotic syndrome may lead to dysregulation of macropinocytosis and 
podocyte toxicity and play an important role in the development of podocyte diseases. 
 
II 
The early events that initiate inflammation in the adipose tissue during obesity are not 
well defined.  It is unclear whether the recruitment of CD8 T cells to the adipose tissue during 
onset of obesity occurs through antigen-dependent or –independent processes.  We have 
previously shown that interaction between NKG2D (natural-killer group 2, member D) and its 
ligand Rae-1 is sufficient to recruit cytotoxic T lymphocytes to the pancreas and induce 
insulitis.  Here, we tested to see whether NKG2D-NKG2D ligand interaction is also involved in 
obesity-induced adipose tissue inflammation and insulin resistance.  We observed a significant 
induction of NKG2D ligand expression in the adipose tissue of obese mice, especially during the 
early stages of obesity.  However, mice lacking NKG2D developed similar levels of insulin 
resistance and adipose tissue inflammation compared to control mice when placed on a high fat 
diet.  Moreover, overexpression of Rae-1 in the adipose tissue did not increase immune cell 
infiltration to the adipose tissue neither in the setting of a normal or high fat diet.  These results 
xv 
 
indicate that, unlike in the pancreas, NKG2D-NKG2D ligand interaction does not play a critical 
role in obesity-induced inflammation in the adipose tissue.
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Regulation of Fluid-phase Uptake in Podocytes by Albumin-associated Lipids 
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INTRODUCTION 
The kidney glomerular filter is a size- and charge-selective barrier that allows the 
filtration of blood without the loss of large serum proteins into the urine.  The filter is composed 
of three layers - fenestrated endothelial cells, the glomerular basement membrane (GBM), and 
podocytes (also known as visceral epithelial cells) (Haraldsson et al. 2008).    Although the 
fenestrations in the endothelial layer are relatively large (approximately 70 nm to 100 nm in 
diameter) and would allow free filtration of fluid and proteins, the fenestrations are covered by a 
glycocalyx-like layer that can provide partial barrier functions.  The GBM, which consists 
mainly of laminin, type IV collagen, nidogen, and heparan sulfate proteoglycans, is thought to 
act as a size- and charge-selective filter or gel.  On the outer aspect of the GBM, podocytes 
spread out across capillary loops and form a tight interdigitating network of cytoskeletal 
extensions known as foot processes.  The space between adjacent foot processes is covered by a 
slit diaphragm, which is composed of cell surface proteins such as nephrin, Neph1, and P-
cadherin.   
Despite significant progress, the exact mechanism of glomerular filtration is yet to be 
completely understood and has been the subject of modeling studies (Edwards et al. 1999; Deen 
et al. 2001; Lazzara and Deen 2001; Smithies 2003).  These current models predict that the size-
selectivity of the GBM is not 100% effective and that it is, at least to a certain extent, permeable 
to serum proteins.  Typically, in humans, approximately 180 liters of blood is filtered by the 
kidney daily.  Even if 99.9% of albumin is prevented from crossing the GBM, as predicted by the 
modeling studies, the high volume of renal blood flow would still result in a significant amount 
of serum protein crossing the GBM.    0.1% of this blood flow would mean that nearly 9 grams 
of albumin and 180 mg of immunoglobulin G (IgG) cross the GBM every 24 hours.  Since the 
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slit diaphragm is considered to be impermeable to large protein molecules such as albumin, we 
considered the possibility that podocytes have a mechanism to actively transport these proteins 
from the GBM into the primary urinary space.  
The notion that podocytes are capable of internalizing and removing proteins from the 
GBM was proposed over 40 years ago (Farquhar et al. 1957; Farquhar et al. 1957).  Numerous 
studies using electron microscopy have shown protein-containing vesicles in podocytes under 
normal and, to an enhanced degree, under nephrotic conditions (Farquhar and Palade 1960; 
Farquhar and Palade 1961; Farquhar et al. 1961; Vogt et al. 1968; Venkatachalam et al. 1970; 
Caulfield and Farquhar 1974).  The constitutive expression of the neonatal Fc receptor, a 
transcytosis receptor for immunoglobulin and albumin, as well as other receptors for 
immunoglobulin and complement, suggests that podocytes may handle this protein by 
internalization and transcytosis (Akilesh et al. 2008).  
Fluid-phase uptake in cells occurs through two distinct processes (Doherty and McMahon 
2009).  Micropinocytosis occurs either during the receptor-mediated endocytosis in a clathrin-
dependent manner or as a constitutive process that internalizes fluids in clathrin-independent 
vesicles.  Micropinocytosis results in small vesicles less than 0.1 μm in diameter.  The second 
process, macropinocytosis, involves the formation of large, 0.2 - 5 μm vesicles that form at sites 
of membrane ruffling (Kerr and Teasdale 2009).  Macropinocytosis is clathrin-independent but 
requires actin, Rac and PI-3 kinase (PI3K).  In certain cells like immature dendritic cells and 
macrophages, macropinocytosis occurs as a constitutive process while in other cells, 
macropinocytosis can be induced by extracellular stimuli like growth factors.  It is a highly 
efficient process allowing internalization of up to one cell volume of fluid/hour.  Because of the 
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larger size of the vesicles, macropinocytosis is also more efficient for the uptake of molecules 
that are larger than 100 kDa in size.  
Here we investigated the endocytic properties of podocytes and discovered an unexpected 
high capacity of podocytes to carry out macropinocytosis.  We found that macropinocytosis in 
podocytes is regulated as it could be induced in response to lipids that were carried by albumin.  
Unlike previously identified regulators of macropinocytosis, we found that lipid-binding G 
protein-coupled receptors (GPCRs) and Gβ/G subunits were involved in stimulating 
macropinocytosis in podocytes.  We propose that exposure of podocytes to albumin-associated 
lipids may act as a signal to trigger macropinocytosis and potentially allow for transcytosis of 
proteins from the GBM into the primary urinary space.   
5 
 
MATERIALS AND METHODS 
 
Reagents   
FITC-Ficoll (70 kDa), FITC-dextran (10, 70, 150, 500, 2000 kDa), bovine serum albumin, 
mouse serum IgG, mannan, p-Chloromercuriobenzoate (pCMB),  wortmannin, cytochalasin D, 
recombinant EGF, ovalbumin, 8-Br-cAMP, 8-pCPT-2′-O-Me-cAMP, forskolin, 3-isobutyl-1-
methylxanthine (IBMX), isoproterenol, fluorescein, anti-podocin Ab, and anti-β-actin Ab were 
obtained from Sigma (St. Louis, MO).  Fatty acid-free bovine serum albumin was purchased 
from SeraCare Life Sciences (Milford, MA).  Human serum albumin was purchased from 
Williams Medical Company (Placentia, CA).  Recombinant PDGF was purchased from Life 
Technologies (Carlsbad, CA).  Anti-phospho-ERK Ab was obtained from Cell Signaling 
Technology (Danvers, MA).  Rhodamine B-dextran (70 kDa) was purchased from Nanocs (New 
York, NY).  Oleic acid, eicosatetraenoic acid, eicosapentaenoic acid, and docosahexaenoic acid 
were obtained from Nu-Chek Prep (Elysian, MN).  Gallein was purchased from Tocris 
Bioscience (Bristol, UK).  Anti-Gβ1 and anti-Gβ2 antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA).  Anti- laminin α5 (Miner et al. 1997) and anti-CD2AP (Dustin 
et al. 1998) antibodies have been previously described. 
 
Mice 
All mice were housed in a specific pathogen-free facility at Washington University 
School of Medicine.  C57BL/6J and 129/SvJ mice were obtained from The Jackson Laboratories 
(Bar Harbor, ME).  Laminin β2 knockout (lamb2-/-) mice with muscle-specific rescue transgene 
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has been previously described (Noakes et al. 1995; Jarad et al. 2006; Miner et al. 2006).  For 
BSA injection experiments, mice (C57BL/6J and 129/SvJ mixed background) were given daily 
intraperitoneal injection of endotoxin-free bovine serum albumin (15 mg/g body weight in PBS) 
for 4 days.  Care and use of mice were conducted in accordance with protocols approved by the 
Animal Studies Committee at Washington University in St. Louis (Protocol Number: 20120013), 
in compliance with the Animal Welfare Act. 
 
Cell culture 
 Conditionally immortalized podocytes were generated as described previously (Mundel 
et al. 1997) and maintained at 33°C in RPMI1640 supplemented with 10% fetal bovine serum,  1 
mM sodium pyruvate, 10  mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM β-
mercaptoethanol, and 100 U/ml recombinant mouse IFNγ (a gift from Robert Schreiber, 
Washington University, St. Louis, MO). 
Bone marrow-derived dendritic cells were cultured as previously described (Lutz et al. 
1999).  Briefly, bone marrow cells were cultured in IMDM supplemented with 10% fetal bovine 
serum (Hyclone), 1 mM sodium pyruvate, 10 mM HEPES, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 0.1 mM β-mercaptoethanol, and 100 ng/ml rGM-CSF (R&D System, Wiesbaden-
Nordenstadt, Germany) for eight days. 
 
Electron microscopy 
Slices of kidney cortex or podocytes cultured on coverslips were fixed overnight in 4% 
paraformaldehyde and 4% glutaraldehyde in 0.1 M sodium cacodylate buffer followed by 
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repeated washes in PBS.  After postfixation in 1% osmium tetraoxide, the samples were reduced 
with 1.5% potassium ferrocyanide for 1 hr at 4˚C.  Subsequently, the samples were washed, 
dehydrated in graded alcohol, and embedded in resin according to standard protocols. 
 
In vivo endocytosis 
 Mice were injected intravenously with a bolus of FITC-Ficoll (70 kDa) or FITC-dextran 
(10 kDa) in 0.9% NaCl at a dose of 250 µg/g of body weight.  24 hrs after injection, kidney was 
harvested from mice, embedded in OCT (VWR, Radnor, PA), and snap-frozen in methylbutane 
cooled in a dry ice-ethanol bath.  Cryosections (8 μm) were applied to charged slides using a 
cryostat. 
For immunofluorescence assays, the kidney sections were fixed with 1% 
paraformaldehyde (PFA) in PBS for 5 min, followed by blocking and permeabilization with 2% 
FBS in PBS with 0.1% saponin.  The slides were incubated with antibodies against laminin 5 or 
podocin for 1 hour at room temperature followed by extensive washing.  Fluorescently 
conjugated secondary antibodies were then applied for 1 h at room temperature.  After several 
washes, the slides were imaged on an Olympus FV1000 confocal microscope (Center Valley, 
PA).  
 
In vitro macropinocytosis assay 
 Mouse podocytes in 6 well plates were serum starved with serum-free RPMI for 2 hours.  
The cells were then incubated in RPMI supplemented with 0.5 mg/ml FITC- or Rhodamine B-
dextran for 30 min on ice or at 37C.  Subsequently the cells were washed three times with ice-
8 
 
cold PBS and fixed with 4% paraformaldehyde for confocal microscopy or trypsinized and 
resuspended in FACS buffer (2% FBS, 2mM EDTA in 1 PBS) for flow cytometry.  FACS data 
was collected on FACSCantoII or LSRII flow cytometers (BD Biosciences, San Jose, CA) and 
analyzed with FlowJo (Treestar, Ashland, OR).        
 
Western Blots  
 Podocytes were lysed in a modified RIPA lysis buffer (50 mM Tris-HCl [pH 7.4], 150 
mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate, 1 mM PMSF, 1 µg/ml 
aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 mM Na3VO4, 1 mM NaF) for 30 min on ice.  
The protein content of the lysates were quantified with a protein assay kit (Bio-Rad).  Equivalent 
amounts of each sample were separated by SDS-PAGE, transferred to nitrocellulose membranes, 
and immunoblotted for phospho-ERK, CD2AP, Gβ1, Gβ2, or β-actin.  The blots were visualized 
by ECL or infrared imaging on a LI-COR Odyssey system (LI-COR, Lincoln, NE). 
    
Lipid extraction 
Lipids were extracted from BSA or HSA using the Bligh-Dyer method with slight 
modifications.  3 ml of 20% BSA in ddH2O was added to a mixture of 6 ml chloroform and 12 
ml methanol in a glass tube and mixed on an orbital shaker for 15 min at room temperature.  6 ml 
of chloroform was added to the mixture while vortexing at low speeds followed by 6 ml of 1 M 
NaCl.  The samples were centrifuged at 1000 RPM for 5 minutes to separate the aqueous and 
organic phases.  The lower organic phase was carefully collected, aliquoted into 1 ml tubes, 
evaporated under vacuum, and stored at -80°C. 
9 
 
For endocytosis assays, the lipids were resuspended in 30 µl of DMSO and the cells were 
treated with 1-5 µl/ml.  Assuming recovery of 80% of the lipids during extraction, this is 
estimated to be equivalent to the amount of lipids bound to BSA in a 0.1 - 0.5 % solution.  
 
Generation of stable podocytes 
Lentiviral constructs containing small hairpin RNAs (shRNAs) targeting FFAR isoforms, 
Gβ isoforms, and firefly luciferase (control) were generated using the pFLRu-YFP lentiviral 
vector (provided by Y. Feng and G. D. Longmore, Washington University, St. Louis, MO) (Feng 
et al. 2010).  The targeting sequence were: fLuc, CCA ACC CTA TTC TCC TTC T; FFAR1, 
ATC TTT GCC TTG GCC CAC TTT G; FFAR2, CGG TTT GCT ACT GAT CCG CAA T; 
FFAR3, ACT GGA ACT GAA GGT AAA GAA T; GNB1, CAT TAT CTG TGG TAT CAC A; 
GNB2, CAT CTG CTC CAT CTA TAG T.  PCR products containing the U6 promoter followed 
by the shRNA sequences were cloned into the pFLRu-YFP vector using the XbaI/XhoI site.  
 For lentivirus production, 293T cells were transfected with the lentiviral constructs along 
with packaging plasmids.  Proliferating podocytes were infected with supernatants containing 
lentivirus and 8 µg/ml protamine sulfate for 24 hours.  7 days after infection, cells expressing 
high levels of YFP were sorted on a BD FACSAria II flow cytometer (BD Biosciences). 
To generate podocytes stably expressing constitutively active Gαs, cells were transfected 
with a pcDNA3.1 vector containing GαS (Q227L) (a gift from Kun-Liang Guan, UCSD).  Stably 
transfected cells were selected by serial passage in 400 µg/ml G418 for 1 week.     
 
cAMP FRET assays 
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A pcDNA3 plasmid containing the FRET-based cAMP biosensor TEpacVV was a gift 
from Kees Jalink (The Netherlands Cancer Institute, Amsterdam, The Netherlands).  Cultured 
podocytes were transfected with TEpacVV using the Nnucleofector system (Lonza, Basel, 
Switzerland) and seeded on glass bottom dishes (MatTek, Ashland, MA).  Images were obtained 
using an Olympus FV1000 confocal microscope in a temperature controlled chamber (37°C).  
The cells were excited at 440 nm and donor and acceptor emission was detected simultaneously 
using a 510 nm beamsplitter and two photomultipliers with optical filters: 465 - 495 nm (CFP) 
and 535 - 565 nm (YFP).   
FRET measurements were quantified using ImageJ (NIH) and the ‘Ratio Plus’ plugin.  
After regions were drawn around individual cells, emission ratios were obtained by calculating 
FRET intensities divided by donor intensities. Time-course ratio measurements were normalized 
to baseline values before stimulation.  The FRET value was set at 1 at the onset of the 
experiment.   
 
Statistical analyses 
Data were routinely presented as mean +/- standard deviation (SD).  We determined 
significance by the Student's t test or ANOVA. We considered a P value of <0.05 as statistically 
significant. 
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RESULTS 
 
Podocytes are highly endocytotic in vivo 
Electron micrographs of the kidney often show intracellular vesicles inside podocytes 
(Fig 1a) (Farquhar and Palade 1960; Farquhar and Palade 1961; Farquhar et al. 1961; Vogt et al. 
1968; Venkatachalam et al. 1970; Venkatachalam et al. 1970; Caulfield and Farquhar 1974).  To 
determine whether these are endocytic vesicles, we injected mice intravenously with two 
different fluorescent fluid-phase markers (70kDa FITC-ficoll or 10kDa FITC-dextran).  24 hours 
after injection, imaging of the kidney glomerulus showed fluorescence labeling in distinct 
vesicles suggesting endocytic uptake (Fig 1b, 2b).   
To determine whether fluid-phase uptake is increased during proteinuria, we performed 
similar experiments with a mouse model of nephrotic syndrome, the laminin β2 knockout 
(lamb2-/-) mice (Noakes et al. 1995; Jarad et al. 2006; Miner et al. 2006).  Lamb2-/- mice have a 
defect in the glomerular filtration barrier, allowing serum proteins to pass into the urine.  
Injection of fluorescent tracers into 3 week-old lamb2-/- mice resulted in significantly increased 
numbers of fluorescently labeled intracellular vesicles that co-localized in cells that labeled with 
podocin, a podocyte-specific marker (Fig 1c and d, 2b and c). 
 
Albumin stimulates macropinocytosis in podocytes 
To test whether fluid-phase endocytosis in podocytes could be studied in vitro, we 
incubated immortalized podocytes in culture with fluid-phase fluorescent markers.  In the 
absence of any stimulus, moderate amounts of uptake were detected by both 
immunofluorescence and flow cytometry when podocytes were incubated with 70 kDa FITC-
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dextran at 37 degrees, but not at 4 degrees (Fig 3a and b).  To mimic proteinuria, when 
podocytes are exposed to increased amounts of serum proteins, we incubated podocytes with 5 - 
15% bovine serum albumin (BSA).  The addition of BSA to the media dramatically increased the 
uptake of the fluid-phase tracers in a dose-dependent manner (Figure 3a-c).  This effect was 
specific to albumin as the addition of immunoglobulin, another abundant protein in the serum, 
did not have any effect (Figure 3d).  Importantly, stimulation of endocytosis by BSA was also 
observed in mice injected with BSA (Fig 4). 
Fluid-phase uptake in cells is carried out by micropinocytosis and macropinocytosis.  
These processes can be distinguished by the size of the endocytic vesicles and their differential 
ability to internalize fluorescent tracers of larger sizes.  BSA stimulation induced the uptake of 
high molecular weight fluorescence tracers (500 kDa and 2000 kDa), suggesting that 
macropinocytosis was the major endocytic process stimulated by BSA (Fig 5a).  
Immunofluorescence imaging confirmed that the size of the fluorescent vesicles ranged from 0.2 
m to 0.6 m, consistent with macropinosomes (Fig 3a).  Macropinocytosis is dependent on 
PI3K activation and actin remodeling and requires aquaporins to expel excess water from the 
vesicles.  Incubation with inhibitors of aquaporin (pCMB), PI3K (wortmannin), or actin 
polymerization (cytochalasin D) blocked dextran uptake in podocytes (Fig 5b).  This confirmed 
that the increased fluid-phase uptake stimulated by BSA was mediated by macropinocytosis. 
A well-known stimulus of macropinocytosis is growth factors.  It has been shown that 
macrophage colony-stimulating factor-1 (CSF-1), epidermal growth factor (EGF), and platelet-
derived growth factor are able to activate macropinocytosis in some cell types (Haigler et al. 
1979; Racoosin and Swanson 1989).  Incubation of podocytes with EGF or PDGF did not 
increase macropinocytosis in podocytes even though downstream targets like ERK were 
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activated (Fig 5c).  The mechanism involved in regulation of macropinocytosis in podocytes is 
therefore distinct from that manifest in dendritic cells.  
Macropinocytosis is thought to be a specialized process specific to certain cell types such 
as dendritic cells and macrophages.  To assess the level of macropinocytosis induced by BSA in 
podocytes, we compared it to the rate of macropinocytosis in immature dendritic cells, a cell 
considered to have a high rate of macropinocytosis (Norbury 2006).  As expected, dendritic cells 
exhibited significantly higher levels of constitutive dextran uptake compared to untreated 
podocytes (Fig 5d).  However, stimulation of podocytes with 7.5% BSA induced a rate of 
macropinocytosis that was comparable to dendritic cells, and at 15% BSA, podocytes surpassed 
dendritic cells in their ability to endocytose dextran (Fig 5d).  BSA did not stimulate fluid-phase 
uptake in dendritic cells, suggesting that the regulatory mechanism of macropinocytosis in 
podocytes is distinct.  
Morphologically, exposure to BSA induced the formation of numerous filopodia and 
actin ring structures (Fig 6).  There was significant activation of actin structures as indicated by 
the enrichment of actin at the cell periphery (Fig 6). These changes are consistent with activation 
of the small GTPase Cdc42, which is known to be associated with induction of macropinocytosis 
(Hall 1998; Garrett et al. 2000).  
 
Lipids bound to albumin are the stimuli for podocyte macropinocytosis 
A major function of albumin is to bind hydrophobic molecules suggesting that 
macropinocytosis in podocytes might be stimulated by the serum lipids present in the 
commercial albumin preparations (van der Vusse 2009).  Delipidated albumin did not induce 
macropinocytosis, suggesting that the albumin protein itself is not the stimulus (Fig 7a).  
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Meanwhile, lipids extracted from the BSA were able to induce fluid-phase uptake (Fig 7b). 
Importantly, lipids extracted from clinical grade human serum albumin (HSA) could also 
stimulate macropinocytosis (Fig 7b), indicating that the lipid activity was not a contaminant but a 
normal physiological lipid present in serum.   
The activity in the lipid extracts was resistant to boiling or hydrolysis in acid or base 
(data not shown).  Incubating the lipids with neutral hydroxylamine (cleavage of thioester bonds), 
methanolic HCl (cleavage of ester, vinyl ether, glycosidic, and amide bonds), or periodate 
(oxidation of diols in sugar moieties) also did not significantly reduce activity (data not shown).  
To purify the active compound, the extracted lipids were separated using silica-based HPLC (Fig 
8).  The fractions that displayed the highest macropinocytosis-stimulating activity were pooled 
together and separated by reverse-phase HPLC (Fig 8).  Mass spectrometric analysis showed that 
these fractions were a complex mixture of hundreds of different lipid molecules (data not shown).  
An analysis of the lipids extracted from HSA showed that the active compound migrated in the 
same fractions on straight and reverse phase HPLC as the active components from BSA (data not 
shown).  This further supports the idea that the bioactive lipid is a physiological lipid present in 
serum. 
In a parallel effort to identify the active lipid compound, we tested a variety of candidate 
lipid molecules.  Initial assays using bioactive lipids (lysophosphatidic acid, prostaglandins, 
lipopolysaccharide, sphingosylphosphorylcholine, etc.) or lipids with various polar head groups 
(choline, ethanolamine, n-dansyl-ethanolamine, n-pyrenesulfonyl-ethanolamine) did not result in 
stimulation of macropinocytosis (data not shown).  We therefore next tested several saturated 
and unsaturated fatty acids of various lengths.  Surprisingly, several different fatty acids 
including oleic acid, eicosatrienoic acid (ETA), eicosapentaenoic acid (EPA), and 
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docosahexaenoic acid (DHA) stimulated macropinocytosis in a dose-dependent manner (Fig 9).  
When added together, the different lipid species had an additive effect on macropinocytosis and 
induced dextran uptake to levels comparable to BSA lipid extracts (Fig 9).  This suggested that 
more than one lipid, including several different fatty acids, might be responsible for inducing 
macropinocytosis in podocytes.  
     
Stimulation of macropinocytosis by albumin-associated lipids is mediated by lipid-binding 
GPCRs and Gβ 
Since many lipids are known to induce signaling in cells using specific receptors, we 
analyzed podocyte microarrays (Akilesh et al. 2011) to identify lipid receptors expressed in 
podocytes focusing on G protein-coupled receptors (GPCRs), the major lipid binding receptors.  
The results showed that podocytes express a variety of fatty acid receptors including FFAR1, 
FFAR2 and FFAR3 (data not shown).  The ligands of FFAR1 are medium- and long-chain fatty 
acids while FFAR2 and FFAR3 bind to short-chain fatty acids.  To determine their roles in 
podocyte macropinocytosis, we used shRNA to knock down all three free fatty acid receptors 
(Fig 10).  Lipid-induced macropinocytosis was significantly decreased when any one of the 
FFAR isoforms were knocked down (Fig 10).   
GPCRs stimulate the disassembly of heterotrimeric G proteins composed of the Gα, Gβ, 
and G subunits.  Upon activation of the receptor, the G protein subunits dissociate from the 
receptor and activate downstream effectors through the free Gα subunit or by the Gβ/Gγ subunit 
complex.  Distinct α subunits activate specific downstream effects including modulation of 
intracellular cAMP concentation.  To determine whether cAMP levels are altered in podocytes in 
response to albumin-associated lipids, podocytes were transfected with a cAMP fluorescence 
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resonance energy transfer (FRET) biosensor and analyzed using time-lapse confocal microscopy.  
Activation with known stimulators of cAMP (Forskolin + IBMX or isoproterenol) induced a 
rapid increase in FRET that was maintained for over 20 minutes or plateaued at a reduced level, 
respectively (Fig 11).  Stimulation with the albumin-associated lipids induced a response that 
was slightly delayed but induced a level of FRET activity similar to isoproterenol within 10 
minutes after exposure (Fig 11). This suggested that albumin-associated lipids activate GPCRs 
that stimulate cAMP production. 
We next tested whether cAMP could induce macropinocytosis in podocytes.  Podocytes 
were treated with forskolin (an activator of adenylate cyclase), 8-bromo-cAMP (a non-selective 
cAMP analog), or 8-CPT-2Me-cAMP (a cAMP analog that activates Epac, but not PKA).  
Contrary to our expectations, none of these manipulations affected dextran uptake (Fig 12a).  
Furthermore, macropinocytosis was not induced when a constitutively active form of GαS 
(Q227L) was overexpressed (Fig 12b).  These results indicate that although cAMP levels change 
in response to lipids, it is not mediating activation of macropinocytosis.  
In addition to triggering the activation of Gα subunit, GPCR signaling induces the release 
and activation of the Gβ/Gγ complex which is known to activate its own set of downstream 
effectors including PI3K and the small GTPases Rac1 and Cdc42.  To determine whether the 
Gβ/Gγ complex was mediating lipid-induced macropinocytosis, we incubated podocytes with 
gallein, an inhibitor of Gβ.  Fluorescein, a compound similar in structure to gallein but does not 
inhibit Gβ, was used as control.  In contrast to fluorescein, gallein reduced basal and lipid-
induced dextran uptake in podocytes (Fig 13a).  In addition, high concentrations of gallein 
almost completely blocked lipid-induced macropinocytosis, suggesting that Gβ/Gγ activity was 
mediating this pathway.  
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These results were confirmed by using shRNA to inhibit expression of Gβ in podocytes.  
Our expression analysis of podocytes showed that of the four Gβ isoforms, only Gβ1 and Gβ2 
are expressed in cultured podocytes (data not shown).   Lentiviral constructs expressing shRNAs 
that target Gβ1 and Gβ2 were generated.  We also generated a construct that contains the two 
shRNAs in tandem to target both isoforms.  YFP co-expressed by the lentivirus allowed us to 
purify transduced cells.  After lentiviral infection, podocytes expressing high levels of YFP were 
sorted using flow cytometry (Fig 14).  Compared to the control (firefly luciferase), the GNB1, or 
the GNB2 knockdown cells, the fraction of YFPhi cells was significantly lower in the 
GNB1/GNB2 double knockdown podocytes.  This was likely due to the deleterious effect of Gβ 
depletion on cell survival and/or proliferation.  Gβ knockdown was confirmed by 
immunoblotting with isoform-specific antibodies that showed nearly complete reduction of 
specific Gβ isoforms in GNB1 and GNB2 single knockdown podocytes (Fig 13b).  Knockdown 
was less efficient in the GNB1/GNB2 double knockdown cells, consistent with the idea that the 
complete absence of Gβ is toxic to the cells.  As expected, knockdown of either Gβ1 or Gβ2 
resulted in an impaired macropinocytotic response to lipid treatment (Fig 13c).  The 
compensatory increase in the expression of the other Gβ isoform in the single knockdown cells 
may have ameliorated the magnitude of the effect on macropinocytosis (Fig 13b).  Indeed, 
knockdown of both Gβ isoforms resulted in a further reduction in macropinocytosis (Fig 13c). 
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DISCUSSION 
 
The presence of large endocytotic vesicles within podocytes is one of the first features 
seen in podocytes using electron microscopy (Farquhar et al. 1957).  These vesicles have been 
speculated to be transcytotic vesicles of primary urine (Vernier et al. 1958) or protein 
reabsorption droplets (Feldman and Fisher 1959; Venkatachalam et al. 1969), phagosomes 
removing subepithelial immune deposits (Rantala 1981) and giant protamine heparin aggregates 
(Sharon et al. 1978).  In the last 10 years, evidence has been accumulating implicating the 
important role of the endocytic pathway in normal and diseased podocytes.  We showed that 
CD2AP hapoinsufficient mice had defects in multivesicular body formation and this was 
associated with subepithelial immunoglobulin deposits and an increased susceptibility to 
glomerular disease (Kim et al. 2003).  More recently Ishibe and colleagues have shown the 
importance of the endocytic proteins, synaptojanin, endophilin and dynamin for the normal 
function of the podocyte (Soda et al. 2012).  The functional significance of these vesicles has 
remained unresolved.  
Our results reveal that these vesicles likely represent macropinosomes and that they 
function to internalize proteins that cross the glomerular basement membrane.  Our studies in 
mice using fluorescent tracers demonstrated that podocytes are capable of significant fluid-phase 
uptake, and that the level of fluid-phase uptake is dramatically increased in proteinuric mice.  As 
the primary defect in the model of nephrotic syndrome that we used (lamb2-/-) mice is in the 
GBM (Noakes et al. 1995; Jarad et al. 2006; Miner et al. 2006), this suggested that the increased 
fluid-phase uptake was not due to pathological changes in podocytes, but rather due potentially 
to stimulating factors in the serum that were traversing the compromised GBM.   
19 
 
Our experiments suggest that macropinocytosis is stimulated by fatty acids that are 
associated with albumin.  While most of our experiments were carried out using BSA, the 
evidence supports the idea that the results we obtained were not due to a contaminant in the 
commercially available BSA preparations.  Lipids isolated from clinical grade HSA behaved by 
HPLC in a manner that was similar to lipids isolated from BSA.  Furthermore, the fatty acids that 
stimulated macropinocytosis are fatty acids present in substantive concentrations in normal 
serum.  The potential effects of endotoxin on our experiments were excluded by multiple assays 
of endotoxin in BSA, which demonstrated insignificant amounts of contamination in the BSA. 
Moreover, LPS treatment had no effect on macropinocytosis (data not shown).  
We found that macropinocytosis in podocytes was stimulated by multiple lipid species 
and was mediated by multiple lipid-binding GPCRs.  Each lipid had a dose-dependent effect on 
endocytosis and we saw an additive effect when we combined the lipids together.  This was 
shown to be mediated by the Gβ/G subunits which are, unlike the Gα subunits, shared by the all 
of the fatty acid receptors and are known to activate key mediators of macropinocytosis (e.g., 
PI3K, Rac1, and Cdc42).  Indeed, macropinocytosis was not affected by manipulating 
intracellular levels of cAMP, a downstream mediator of GαS, but was inhibited by chemical 
inhibitors or shRNA-mediated knockdown of Gβ. 
The role of macropinocytosis has been shown to vary depending on cell type.  Certain 
cell types exhibit constitutive macropinocytosis.  For example, immature dendritic cells use 
macropinocytosis as a means of surveying the surrounding environment for foreign pathogens 
(Sallusto et al. 1995).  For axenic strains of Dictyostelium and Ras-transformed cells, 
macropinocytosis serves as a major supply pathway for nutrients (Hacker et al. 1997; Commisso 
et al. 2013).  In other situations, macropinocytosis is transiently induced by certain stimuli such 
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as phorbol esters or growth factors such as EGF or CSF-1 (Haigler et al. 1979; Racoosin and 
Swanson 1989; Swanson 1989).   
In the case of podocytes, we propose that macropinocytosis functions to remove large 
serum proteins that are able to enter and cross the GBM.  In the sieving model of the glomerular 
filtration barrier, the endothelial fenestrations, the collagen and laminin matrix of the GBM, and 
the pores of the slit-diaphragm function together to form an efficient size-selective filter, 
preventing the passage of molecules larger than 60kD.  It has been argued that such models 
would require an active clearance mechanism to prevent the filter from clogging.  This has led to 
alternative models where the filtration barrier is thought to function more as a gel, allowing the 
passage of all molecules but limiting the molecular transit in a manner that is inversely 
proportional to the size of the molecule.  In either case, both models would require an active 
mechanism to handle large molecules that cross the GBM.  The high expression of receptors for 
albumin, IgG, and complement on the podocyte support the idea that the podocyte plays a 
specialized role in recycling of serum proteins that cross the GBM.   
Since macropinocytosis is an energy consuming process, it seems reasonable that 
podocytes would regulate their level of macropinocytosis with the amount of serum proteins that 
have crossed the barrier.  Our data suggest that podocytes respond to fatty acids that are bound to 
albumin and the recognition of fatty acids serves as a proxy for albumin.  It is interesting that 
multiple fatty acid species were able to stimulate macropinocytosis through several different 
receptors.  We speculate that this redundancy allows podocytes to detect a broader spectrum of 
ligands and ensures induction of a response regardless of fluctuations in the serum levels of 
individual lipid molecular species. It also suggests that metabolic or inflammatory conditions 
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that alter the type and amount of fatty acid molecular species could also have an effect on 
podocyte function and the glomerular filtration barrier.   
Macropinocytosis could also be important in podocytes as a source of energy and 
nutrition.  Podocytes are unique in that they are located wholly in the urinary space and are 
separated from the blood supply by the GBM.  The filtration barrier might function to restrict 
access to certain types of nutrients, partially explaining why podocytes exhibit constitutive 
autophagy and why impairing autophagy is so detrimental to podocytes (Burgess et al. 2008; 
Bour et al. 2009).  It is plausible to speculate that, as in amoeba and Ras-transformed cells 
(Hacker et al. 1997; Commisso et al. 2013), serum proteins internalized via macropinocytosis are 
degraded and used as a source of energy and anabolic substrates.  Time-lapse experiments 
revealed that macropinocytic vesicles indeed merged with lysosomal compartments over time 
(data not shown).   
The fact that macropinocytosis at basal states is low and only induced transiently suggest 
that sustained activation of macropinocytosis could be detrimental.  The level of 
macropinocytosis induced during proteinuric states is likely maladaptive.  In support of this 
notion, we observed swollen podocytes with numerous protein-filled vesicles and partially fused 
foot processes in mice injected with BSA for up to 8 days (data not shown).  Chronic stimulation 
of macropinocytosis may lead to excessive uptake of fluids and serum proteins that overload the 
degradative pathway leading to cell dysfunction.  Accumulation of albumin in podocytes has 
been shown to be toxic and lead to podocyte loss as well as glomerulosclerosis (Barnes and 
Karin 1997; Cai et al. 2005; Bastarrachea et al. 2007; Chen et al. 2011).  In addition, it has been 
demonstrated recently that hyperstimulation of macropinocytosis leads to lysosomal dysfunction 
and cell death (Overmeyer et al. 2008; Li et al. 2010; Nara et al. 2012).  Chronic activation of 
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Rac1 and/or Cdc42 stimulated by the fatty acids could also lead to exacerbation of proteinuria.  
We and others have demonstrated that dysregulation of Rac1 or Cdc42 in podocytes leads to 
podocyte foot process effacement and proteinuria in mice (Carr et al. 2004; Carr et al. 2005; 
Scott et al. 2012; Blattner et al. 2013).  Thus, we suspect that low level exposure of podocytes to 
fatty acids allows for macropinocytosis-mediated maintenance of the glomerular filter, but 
sustained stimulation by fatty acids could lead to foot process effacement and persistent 
proteinuria.   
Hyperlipidemia is one of the defining characteristics of nephrotic syndrome, a severe 
proteinuric condition caused by podocyte dysfunction.  Our work suggests that exposure to 
elevated serum lipid concentrations in nephrotic states could be a cause of podocyte dysfunction.  
In support of this idea, numerous studies have reported reductions in proteinuria and 
improvements in renal function in nephrotic patients treated with lipoprotein apheresis to reduce 
hyperlipidemia (Hattori et al. 1993; Yorioka et al. 1997; Yokoyama et al. 1998; Muso et al. 
1999; Daimon et al. 2000; Stenvinkel et al. 2000; Muso et al. 2001; Hattori et al. 2003; 
Nakamura et al. 2005; Carr et al. 2006; Caspar-Bauguil et al. 2006).  This implies that free fatty 
acids may function as a key player in a vicious cycle that sustains proteinuria.  An initial trigger 
for proteinuria (i.e., infection, toxins, inflammation) would lead to loss of albumin and decreased 
lipid-buffering capacity of serum, resulting in an increase of uncomplexed lipids.  This would 
result in increased exposure of podocytes to free fatty acids, causing further podocyte damage 
and foot process effacement through activation of Rac/Cdc42 and/or lysosomal dysfunction, 
thereby perpetuating the cycle of macropinocytosis and proteinuria.  Thus it will be interesting to 
see whether chronic stimulation of the macropinocytic pathway by serum lipids is a mechanism 
driving the pathogenesis of nephrotic syndrome.   
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In conclusion, we have described an inducible system of macropinocytosis in podocytes.  
A number of different lipid species bound to albumin in serum can stimulate macropinocytosis in 
podocytes though lipid-binding receptors and signaling through Gβ/Gγ.  We propose a model in 
which podocytes detect accumulation of proteins in the subepithelial space via lipids and 
subsequently remove them by engaging a highly efficient mechanism of endocytosis.  This has 
the role of preventing the glomerular filtration barrier from clogging and/or providing a source of 
energy for the podocytes, but may have maladaptive consequences when sustained chronically.  
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Figure 1.  Podocytes are highly endocytotic cells in vivo and endocytosis is stimulated under 
proteinuric conditions 
(A) Cross-section of the glomerular filter of a wild-type mouse obtained by electron microscopy. 
Arrows indicate vesicles located inside podocytes.  (B-D) Wild-type (B) or lamb2-/- mice (C, D) 
were intravenously injected with 70 kDa FITC-ficoll (green).  24 hrs after injection, glomerular 
sections were stained for laminin α5 (B, C) or podocin (D) (red) and counterstained with DAPI 
(blue).  Insets are enlarged images of the indicated area.  
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Figure 2.  Podocytes are highly endocytotic cells in vivo and endocytosis is stimulated under 
proteinuric conditions 
(A-C) Wild-type (A) or lamb2-/- mice (B, C) were intravenously injected with 10 kDa FITC-
dextran (green).  24 hrs after injection, glomerular sections were stained for laminin α5 (A, B) or 
podocin (C) (red) and counterstained with DAPI (blue).  Insets are enlarged images of the 
indicated area. 
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Figure 3.  Albumin stimulates fluid-phase uptake in cultured podocytes 
(A) Cultured podocytes were incubated with or without 10% BSA at 4°C or 37°C in the presence 
70 kDa FITC-dextran for 30 minutes and analyzed by fluorescence microscopy.   Upper inset is 
an enlarged image of the indicated area.  Lower inset is an electron microscopy image of a 
cultured podocyte incubated with 10% BSA.  Scale bars are 0.5 µm.  (B) Cells treated identical 
to (A) were analyzed by flow cytometry.  (C, D) Podocytes were incubated with indicated 
concentrations of BSA or IgG in the presence of 70 kDa FITC-dextran for 30 minutes and 
analyzed by flow cytometry.  Results are shown as fold change in mean fluorescence intensity.  
The data represent mean ± SD of 3 independent experiments.  * p<0.05, ** p<0.01 
  
29 
 
  
30 
 
 
 
 
 
 
 
 
 
Figure 4.  Albumin stimulates fluid-phase uptake in podocytes in mice 
(A-D) Control mice (A) or mice given daily injections of BSA for 4 days (B, C) were 
intravenously injected with 70 kDa FITC-ficoll (green).  24 hrs after injection, glomerular 
sections were stained for laminin α5 (A, B) or podocin (C) (red) and counterstained with DAPI 
(blue).  Insets are enlarged images of the indicated area.  (D) The glomerulus of mice injected 
daily with BSA for 4 days was analyzed by electron microscopy. Arrows indicate protein-filled 
vesicles located inside podocytes. 
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Figure 5.  Albumin stimulated fluid-phase uptake in podocytes occurs by macropinocytosis 
(A) Podocytes were incubated with 70 kDa, 500 kDa, or 2000 kDa FITC-dextran in the presence 
of 7.5% BSA and mannan (1 mg/ml) as indicated for 30 minutes and analyzed by flow 
cytometry.  (B) Podocytes were pretreated with pCMB (100 µM), wortmannin (1 µM), or 
cytochalasin D (10 µM) for 30 min.  Subsequently, the cells were incubated with 15% BSA in 
the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry.  (C) Podocytes 
were incubated with EGF (100 nM) and PDGF (25 nM) in the presence of FITC-dextran for 30 
minutes and analyzed by flow cytometry.  Inset is an immunoblot of cells for ERK 
phosphorylation and CD2AP as loading control. (D) Bone-marrow derived dendritic cells and 
podocytes were incubated with BSA as indicated in the presence of FITC-dextran for 30 minutes 
and analyzed by flow cytometry.  All results are shown as fold change in mean fluorescence 
intensity.  The data represent mean ± SD of 3 independent experiments.  * p<0.05, ** p<0.01 
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Figure 6.  Albumin stimulates formation of actin structures in podocytes  
Podocytes were fixed after incubating with 5% BSA for 5 minutes, stained with phalloidin, and 
analyzed with fluorescence microscopy.  Insets are enlarged images of the indicated area 
displaying formation of filopodia (upper) and actin ring structures (lower). 
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Figure 7.  Podocyte macropinocytosis is stimulated by albumin-associated lipids  
(A) Podocytes were incubated with 7.5% BSA or fatty acid-free BSA in the presence of FITC-
dextran for 30 minutes and analyzed by flow cytometry.  (B) Podocytes were incubated with 
7.5% BSA, BSA lipid extract, or HSA lipid extract in the presence of FITC-dextran for 30 
minutes and analyzed by flow cytometry.   All results are shown as fold change in mean 
fluorescence intensity.  The data represent mean ± SD of 3 independent experiments.  * p<0.05, 
** p<0.01 
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Figure 8.  Fractionation of albumin-associated lipids by HPLC 
(A) Lipids extracted from BSA were fractionated by silica-based HPLC and each fraction was 
tested for ability to induce macropinocytosis in podocytes.  (B) Fractions 20 and 21 from (a) 
were combined and fractionated by reversed-phase HPLC.  Each fraction was again tested for 
macropinocytosis induction.  Fraction 52 was further analyzed by mass spectrometry.  All results 
are shown as fold change in mean fluorescence intensity. 
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Figure 9.  Podocyte macropinocytosis is stimulated by free fatty acids  
(A) Podocytes were incubated with increasing concentrations (1 or 10 µM) of lipids as indicated 
in the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry.  (D) Podocytes 
were incubated with individual lipids (2 µM) or a mixture of the lipids (2 µM each) in the 
presence of FITC-dextran for 30 minutes and analyzed by flow cytometry.  All results are shown 
as fold change in mean fluorescence intensity.  The data represent mean ± SD of 3 independent 
experiments. * p<0.05, ** p<0.01 vs DMSO. 
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Figure 10.  Stimulation of macropinocytosis by albumin-associated lipids is mediated by free 
fatty acid receptors 
(A) FFAR knockdown podocytes were analyzed by real time quantitative PCR.  Results are 
shown as fold change of mRNA levels compared to control (firefly luciferase) knockdown cells.  
* p<0.05, ** p<0.01 vs. fLuc control.  (B) Control and FFAR knockdown podocytes were 
incubated with Rhodamine B-dextran and BSA lipid extracts for 30 min and analyzed by flow 
cytometry.  Results are shown as fold change in mean fluorescence intensity.  The data represent 
mean ± SD of 3 independent experiments.  * p<0.05 
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Figure 11.  Albumin-associated lipids induce GαS activation in podocytes 
(A) Podocytes expressing the cAMP FRET sensor TEpacVV were treated with Forskolin (25 µM) 
+ IBMX (100 µM), Isoproterenol (10µM), or 3 µl/ml BSA lipid extract and analyzed by real 
time confocal microscopy.  Compounds were added at 4 min.  Brighter intensity indicates higher 
CFP/YFP ratios.  (B) Changes in CFP/YFP ratios are plotted against time.  Arrow indicates time 
of treatment.  (n= 4, Forskolin + IBMX; 4, Isoproterenol; 10, BSA lipid extract)   
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Figure 12.  Stimulation of macropinocytosis by albumin-associated lipids is not mediated by 
Gα activation 
(A) Podocytes were incubated with 3 µl/ml BSA lipid extract, forskolin (10 µM), 8-Br-cAMP 
(10 µM), or 8-CPT-2Me-cAMP (10 µM) in the presence of FITC-dextran for 30 minutes and 
analyzed by flow cytometry.  (B) Control or podocytes expressing constitutively active GαS 
(Q227L) were incubated with BSA lipid extract in the presence of FITC-dextran for 30 minutes 
and analyzed by flow cytometry.  Results are shown as fold change in mean fluorescence 
intensity.  The data represent mean ± SD of 3 independent experiments.  * p<0.05 
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Figure 13.  Stimulation of macropinocytosis by albumin-associated lipids is mediated by Gβ 
activation 
(A) Podocytes were pretreated with 2 or 10 µM fluorescein or gallein for 30 minutes.  
Subsequently, the cells were incubated with BSA lipid extracts in the presence of Rhodamine B-
dextran for 30 min and analyzed by flow cytometry.  (B) Podocytes expressing shRNAs 
targeting firefly luciferase (fLuc), GNB1, GNB2, or GNB1 and 2 (GNB1/2) were immunoblotted 
for Gβ1 and Gβ2 expression.  β-actin was used as loading control.  (C) GNB knockdown 
podocytes were incubated with BSA lipid extracts in the presence of Rhodamine B-dextran for 
30 min and analyzed by flow cytometry.  Results in (A) and (C) are shown as fold change in 
mean fluorescence intensity.  The data represent mean ± SD of 3 independent experiments.  * 
p<0.05, ** p<0.01 
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Figure 14.  Flow cytometry analysis of podocytes infected with GNB knockdown lentivirus 
(A-E)  Podocytes were infected with lentiviral vectors expressing YFP and shRNAs targeting 
firefly luciferase (fLuc) or different GNB isoforms.  Cells expressing high levels of YFP (gated 
region) were sorted and used for further analysis.  Note the lower number of YFP-positive cells, 
especially the significant reduction of the YFPhi populations in podocytes infected with 
GNB1/GNB2 shRNA lentivirus (E).  
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INTRODUCTION 
 
Chronic kidney disease (CKD), which refers to the progressive loss of renal function, 
affects millions of people in the United States (NIDDK 2009).  CKD is classified into 5 stages 
based on the extent of kidney damage and pathology including glomerular filtration rate, plasma 
creatinine, and proteinuria levels.  The final stage, also known as end stage renal disease 
(ESRD), is the complete loss of kidney function, when the patient cannot continue daily life 
without dialysis or a transplant.  Diabetes and hypertension the leading causes of ESRD.  In 
addition, mutations in several genes involved in maintaining the structure and function of the 
kidney have been linked to CKD (Friedman and Pollak 2011) .   
African Americans develop ESRD at four to five times higher rates than European 
Americans.  In 2008, two studies utilizing mapping by admixture linkage disequilibrium 
(MALD) identified a locus in chromosome 22 (which included the MYH9 gene) that conferred 
the increased risk for nondiabetic kidney diseases in African Americans (Kao et al. 2008; Kopp 
et al. 2008).  However, subsequent studies failed to provide convincing evidence to support the 
etiological role of Myh9 in CKD.  Later, two groups incorporated data from the 1000 genomes 
project and identified two coding sequence variants in APOL1, a gene immediately downstream 
of MYH9, that had the strongest associations with CKD in African Americans (Genovese et al. 
2010; Tzur et al. 2010).  The two variants are referred to as G1 (S342G and I384M substitutions) 
and G2 (deletion of N388 and Y389).  Approximately 50% of the African American population 
have either one or two risk alleles, and individuals carrying both G1 and G2 alleles have a 
significantly increased risk of focal segmental glomerular sclerosis (FSGS), hypertension-
associated ESRD (H-ESRD), and HIV-associated nephropathy (HIVAN). 
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ApoL1 was originally identified as a minor component of high-density lipoprotein 
(HDL) (Duchateau et al. 1997).  Five additional ApoL isoforms have since been identified and 
are located in a tight cluster from chromosome 22q12.3 to 13.1 (Duchateau et al. 2001; Page et 
al. 2001).  It is expressed only in humans and certain primates, but not in rodents.  ApoL1 has 
been shown to be able to bind various lipid species including phosphatidic acids, cardiolipin, and 
phosphoinositides (Wan et al. 2008; Zhaorigetu et al. 2008).  In addition, clinical data reveal an 
association of ApoL1 with hyperlipidemia (Duchateau et al. 2000; Albert et al. 2005; Li et al. 
2009).  These results indicate that ApoL1 is involved in lipid handling and transport. 
ApoL1 is also involved in trypanosome immunity, apoptosis, and autophagy.  When 
circulating ApoL1 is endocytosed by trypanosomes and trafficked to the lysosome, it undergoes 
a conformational change to form an anion channel.  This causes swelling of the lysosome and 
eventually kills the trypanosome (Vanhamme et al. 2003; Perez-Morga et al. 2005).  In addition, 
ApoL1 was shown to be a novel BH3-only protein that induces autophagic cell death when 
overexpressed in various cancer cell lines (Wan et al. 2008; Zhaorigetu et al. 2008). 
Despite mounting evidence of its genetic association, it is still unclear how mutations in 
ApoL1 predispose carriers to CKD.  In a study by Reeves-Daniel et al., donor kidneys with 
ApoL1 risk alleles had a higher incidence of early failure when transplanted (Reeves-Daniel et 
al. 2011).  This indicates that alteration of ApoL1 function in the kidney is, at least in part, 
responsible for increased susceptibility to CKD.  In normal kidney, ApoL1 is expressed 
exclusively in podocytes (Madhavan et al. 2011).  Podocytes are epithelial cells that form 
interdigitating foot processes which wrap around the capillaries in the glomerulus (Greka and 
Mundel 2012).  The space between the foot processes is connected by a network of proteins 
known as the slit diaphragm, which along with the glomerular basement membrane, form the 
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sieve through which blood is filtered to make urine.  Disruption of the foot processes or loss of 
podocytes leads to massive proteinuria, a hallmark of renal failure.  Thus, it is reasonable to 
speculate that ApoL1 may be required for normal function and/or survival of podocytes. 
It has long been suspected that abnormal lipid metabolism can lead to kidney 
dysfunction.  Obesity increases the risk of CKD independent of hypertension and diabetes 
(Wahba and Mak 2007).  In addition, hypertriglyceridemia and hypercholesterolemia are 
associated with podocyte damage and mesangial sclerosis (Joles et al. 2000).  Interestingly, lipid 
accumulation in the glomeruli and tubules of kidney has been observed in various models of 
kidney dysfunction in mice and human (Bobulescu 2010).  Lipid accumulation in cells not 
equipped to handle excess lipids is known to cause cellular dysfunction and apoptosis in a 
process termed lipotoxicity (Schaffer 2003). 
Based on these observations, we investigated whether podocytes are sensitive to lipid-
induced cell toxicity.  The possible role of ApoL1 in protecting podocytes from hyperlipidemic 
conditions is also examined.  
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MATERIALS AND METHODS 
 
Cell culture 
 Conditionally immortalized mouse podocytes were generated as described previously 
(Mundel et al. 1997) and maintained at 33°C in RPMI1640 supplemented with 10% fetal bovine 
serum,  1 mM sodium pyruvate, 10 mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 
0.1 mM β-mercaptoethanol, and 100 U/ml recombinant mouse IFNγ (a gift from Robert 
Schreiber, Washington University, St. Louis, MO). 
 Conditionally immortalized human podocytes were a gift from Moin Saleem (University 
of Bristol, UK).  The cells were maintained at 33°C in RPMI1640 supplemented with 10% fetal 
bovine serum, 10 µg/ml insulin (Sigma), 5.5 µg/ml transferrin (Sigma), 5 ng/ml sodium selenite 
(Sigma), 1 mM sodium pyruvate, 10 mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 
0.1 mM β-mercaptoethanol as previously described (Saleem et al. 2002).   
 
Lipotoxicity assays 
For palmitate-induced cell death assays, palmitic acid or oleic acid (Nu-Chek Prep) was 
conjugated to BSA at a 2:1 molar ratio.  Podocytes at 40 - 50% confluency were incubated in 
complete growth medium and BSA-fatty acid conjugates for 24 or 48 hours.      
 For cholesterol-induced cell death assays, podocytes were loaded with free cholesterol 
by incubating the cells with 100 µg/ml acetyl-LDL (Alfa Aesar, Ward Hill, MA) for 24 hours in 
the presence of 10 µg/ml Sandoz 58035 (Sigma), which inhibits ACAT-mediated cholesterol 
esterification (Yao and Tabas 2000). 
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At the end of the incubation period, the cells were collected, stained with Annexin V 
antibodies and PI or 7AAD using an apoptosis detection kit (BD biosicences), and analyzed on a 
BD FACSCantoII flow cytometer (BD biosicences) and FlowJo (Treestar). 
 
Podocyte transfection 
 Mammalian expression vectors (pCMV6-AC-GFP) containing the cDNAs of ApoL1 – 4 
and a C-terminal GFP tag were purchased from Origene (Rockville, MD).  G1 (S342G, I384M) 
and G2 (deletion of N388 and Y389) variants of ApoL1 were generated by site-directed 
mutagenesis from the pCMV-ApoL1-GFP construct using the QuikChange Site-Directed 
Mutagenesis Kit (Agilent Technologies, Santa Clara, CA).  
 Immortalized mouse podocytes were transfected with the Nucleofector Kits for 
Mammalian Epithelial Cells (Lonza, Basel, Switzerland) using the protocol number T-020.  The 
cells were maintained for 24 hours after nucleofection before treatment of fatty acids for 
lipotoxicity assays. 
 
Generation of ApoL1 knockdown podocytes 
Lentiviral constructs containing small hairpin RNAs (shRNAs) targeting ApoL1 and 
firefly luciferase (control) were generated using the pFLRu-YFP lentiviral vector (provided by Y. 
Feng and G. D. Longmore, Washington University, St. Louis, MO) (Feng et al. 2010).  The 
targeting sequences were: fLuc, CCA ACC CTA TTC TCC TTC T; ApoL1, GGA CAA CCT 
TGC AAG ACA A.  PCR products containing the U6 promoter followed by the shRNA 
sequences were cloned into the pFLRu-YFP vector using the XbaI/XhoI site.  
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 For lentivirus production, 293T cells were transfected with the lentiviral constructs along 
with packaging plasmids.  Proliferating podocytes were infected with supernatants containing 
lentivirus and 8 µg/ml protamine sulfate for 24 hours.  7 days after infection, cells expressing 
high levels of YFP were sorted on a BD FACSAria II flow cytometer (BD Biosciences). 
 
Western Blots  
 Podocytes were lysed in a modified RIPA lysis buffer (50 mM Tris-HCl [pH 7.4], 150 
mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate, 1 mM PMSF, 1 µg/ml 
aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 mM Na3VO4, 1 mM NaF) for 30 min on ice.  
The protein content of the lysates were quantified with a protein assay kit (Bio-Rad).  Equivalent 
amounts of each sample were separated by SDS-PAGE, transferred to nitrocellulose membranes, 
and immunoblotted with antibodies against ApoL1 (Sigma) or β-actin (Sigma).  The blots were 
visualized by ECL. 
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RESULTS 
 
Podocytes are sensitive to palmitate-induced cell death, but not cholesterol-induced cell death 
Numerous studies have reported that long-chain fatty acids but not unsaturated fatty acids 
induce apoptosis in cells such as pancreatic β-cells, cardiac myocytes, and skin fibroblasts 
(Rosenthal 1981; Zhang et al. 1992; de Vries et al. 1997; Maedler et al. 2001).  In order to 
determine whether podocytes are sensitive to lipotoxicity, immortalized mouse podocytes were 
incubated with increasing concentrations of BSA-conjugated palmitatic acid or oleic acid.  
Results showed that palmitic acid induced podocyte apoptosis in a dose-dependent manner while 
oleic acid did not induce cell death even at the highest concentrations tested (Fig. 1a and b).  Cell 
death was detectable at after 24 hours and was significantly increased after 48 hours (Fig 1c).  
Palmitic acid was similarly induced apoptosis in human podocytes (data not shown).   
Intracellular accumulation of unesterified cholesterol has also been shown to induce cell 
toxicity (Warner et al. 1995).  Mouse podocytes were loaded with free cholesterol by incubating 
in acetylated-LDL in the presence of Sandoz 58-035, which inhibits acetyl-coenzyme A 
acetyltransferase (ACAT)-mediated cholesterol esterification.  In contrast to palmitic acid, there 
was no increase in podocyte cell death after cholesterol overload (Fig 2).  
 
ApoL1 protects podocytes from palmitate-induced cell death 
ApoL1 is only expressed in higher primates and is therefore absent in mouse podocytes.  
To determine whether ApoL1 could protect podocytes from palmitate-induced cell death, cells 
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were transfected with GFP-tagged ApoL1 and treated with palmitic acid.  Analyses using flow 
cytometry revealed that ApoL1-expressing GFP+ cells were more resistant to palmitate-induced 
cell death than GFP- cells (Fig 3a and b). 
Isoforms of ApoL1 appear to have risen from recent gene duplication and have a high 
level of homology at the level of amino acid sequence (Page et al. 2001).  Assays using cells 
overexpressing GFP-tagged ApoL2, 3, and 4 demonstrated that ApoL3 can also protect 
podocytes from lipotoxicity, albeit to a lesser degree than ApoL1 (Fig 3b). 
To confirm these findings, shRNA-mediated gene silencing was used to knockdown the 
expression of ApoL1 in immortalized human podocytes (Fig 4a).  Reduction of ApoL1 did not 
affect cell viability in cells cultured with BSA or BSA-conjugated oleic acid (Fig 4b).  In 
contrast, when incubated in palmitic acid, podocytes expressing decreased levels of ApoL1 
displayed significantly higher rates of apoptosis as indicated by Annexin V and 7AAD staining 
(Fig 4b).  
 
ApoL1 G1 and G2 variants have similar effects in reducing lipotoxicity compared to wild-type 
ApoL1 
 The increased risk of CKD in populations of African descent has been attributed to the 
G1 and G2 sequence variants in the ApoL1 gene (Genovese et al. 2010).  Mouse podocytes were 
transfected with either wild-type or the G1 or G2 variants of ApoL1-GFP and treated with BSA-
conjugated palmitic acid for 24 hours.  Analysis of the ratio of GFP+:GFP- cells in the viable 
fraction revealed that the G1 and G2 mutations do not have an effect on the ability of ApoL1 in 
modulating lipotoxicity (Fig 5).   
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DISCUSSION 
 
 One of the hallmarks of nephrotic syndrome is hyperlipidemia, or abnormal elevation of 
serum lipid levels.  It was recently demonstrated that the elevated serum ratio of free fatty acids 
to albumin caused by proteinuria stimulates secretion of angiopoietin-like 4 (Angptl4) from heart, 
muscle, and adipose tissues (Clement et al. 2014).  The circulating Angptl4 reduces uptake of 
free fatty acids in the peripheral organs by inhibiting lipoprotein lipase (LPL) and thereby causes 
hyperlipidemia.  This indicates that dysregulation of serum lipid levels is a result of protein loss 
during nephrotic states. 
 However, there several lines of evidence suggest that lipids could directly cause renal 
injury.  Hyperlipidemia has been shown to be an independent risk factor for developing 
proteinuria and chronic kidney diseases (Samuelsson et al. 1998; Tozawa et al. 2002; Schaeffner 
et al. 2003; Astor et al. 2006; Lee et al. 2009).  In addition, numerous studies have demonstrated 
that lipoprotein apheresis to reduce hyperlipidemia effectively reduces proteinuria and improves 
renal function in nephrotic patients (Hattori et al. 1993; Yorioka et al. 1997; Yokoyama et al. 
1998; Muso et al. 1999; Daimon et al. 2000; Stenvinkel et al. 2000; Muso et al. 2001; Hattori et 
al. 2003; Nakamura et al. 2005; Carr et al. 2006; Caspar-Bauguil et al. 2006).  Furthermore, 
rodent models with genetically- or diet-induced hyperlipidemia develop progressive glomerular 
damage (Koletsky 1975; Imai et al. 1977; Kasiske et al. 1985; Keane et al. 1991; Grone et al. 
1993; Ruan et al. 2003).  The pathological effects of lipids on renal function have been attributed 
to the induction of inflammatory stress, oxidative stress, and endoplasmic reticulum stress (Ruan 
et al. 2009).   
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 Our results demonstrate that saturated fatty acids can directly induce apoptosis in 
podocytes.  These results have been confirmed by recent reports of similar findings (Sieber et al. 
2010; Yasuda et al. 2014).  This suggests that free fatty acids may play a prominent role in the 
development of podocyte diseases.  In healthy subjects, the vast majority (more than 99.9%) of 
free fatty acids in the serum is bound to albumin (Richieri and Kleinfeld 1995), and the amount 
of saturated fatty acids that podocytes are exposed to would be insufficient to cause injury.  
However, increased serum lipid concentrations manifest in obese and diabetic subjects would 
result in elevated levels of unbound fatty acids.  This could trigger podocyte injury and induce 
proteinuria.  Loss of albumin due to proteinuria, and the subsequent decrease in the fatty acid 
buffering capacity of the serum, would then further increase in the levels of unbound fatty acids.  
Saturated fatty acids could therefore act as both an initial trigger of podocyte injury as well as a 
mediator of a vicious cycle.  Interstingly, it has been shown that free fatty acids can also cause 
tubulointerstitial injury, demonstrating that the lipotoxic effects of fatty acids are not limited to the 
glomerulus (Kamijo et al. 2002; Thomas et al. 2002).   
 Genetic association studies have provided very compelling data implicating the role of 
ApoL1 in the development of chronic kidney diseases (Genovese et al. 2010; Tzur et al. 2010; 
Genovese et al. 2013).  However, the function of ApoL1 and the mechanisms underlying the 
association of ApoL1 sequence variants with increased risk of developing chronic diseases have 
not been elucidated.  We provide evidence that ApoL1 is able to dampen the lipotoxic effects of 
palmitic acid in podocytes.  This was demonstrated by overexpressing ApoL1 in mouse 
podocytes, which do not express ApoL1, or by knocking down ApoL1 expression in human 
podocytes.   
 ApoL1 was initially identified as a component of HDL (Duchateau et al. 1997), and has 
thus been predicted to have functions related to lipid transport.  In support of these speculations, 
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ApoL1 is capable of binding to several lipid species, such as phosphatidic acid, cardiolipin, and 
phosphoinositides (Wan et al. 2008).  Our results suggest that ApoL1 may be involved in the 
binding and sequestering of intracellular fatty acids or the export of fatty acids.  Disruption of 
ApoL1 function in podocytes may result in the loss of the ability to cope with increased influx of 
fatty acids.  Notably, ApoL3, another member of the ApoL family with a high degree of 
homology to ApoL1, also decreased palmitate-induced cell death in podocytes suggesting that it 
could have similar functions with ApoL1. 
 The G1 (S342G and I384M) and G2 (N388, Y389 deletion) mutations did not affect the 
‘lipo-protective’ properties of ApoL1.  One explanation is that the residues mutated in the G1, 
G2 variants and the associated increase in susceptibility to renal injury are not related to the 
lipid-handling aspects of ApoL1 function.  On the other hand, it is possible that the lipid-related 
functions of ApoL1 are indeed important for podocyte function and survival, and the G1 and G2 
residues are merely residues that are in close linkage to the actual amino acids critical for ApoL1 
function in lipid handling.  Further association studies with larger samples sizes may reveal 
additional sequence variations in the ApoL1 gene to be investigated. 
 In conclusion, these results demonstrate the potential role of saturated free fatty acids in 
the pathogenesis of podocyte diseases and suggest a possible mechanism to explain the 
association of ApoL1 with chronic kidney diseases.      
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Figure 1.  Podocytes are sensitive to palmitate-induced cell death 
(A, B) Mouse podocytes were incubated with 250 µM BSA or fatty acids conjugated to BSA 
(FFA:BSA ratio 2:1) at indicated concentrations for 48 hours.  (A) Cells were stained with α-
Annexin V Ab and PI and analyzed by flow cytometry.  Percent of PI+ cells are depicted in (B).  
(C)  Mouse podocytes were incubated with BSA or fatty acids conjugated to BSA as indicated 
for 24 or 48 hours.  Percent of Annexin V+ cells are shown. 
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Figure 2.  Podocytes are resistant to cholesterol-induced cell death 
Mouse podocytes were pretreated with 10 µg/ml Sandoz 58-035 or DMSO for 24 hours.  
Subsequently, cells were incubated with 100 µg/ml acetyl-LDL for 24 hours, stained with 7AAD 
and analyzed by flow cytometry.  
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Figure 3. Overexpression of ApoL1 in podocytes reduces palmitate-induced cell death 
(A) Mouse podocytes were transfected with ApoL1-GFP.  24 hours after transfection, the cells 
were treated with 500 µM palmitate for 24 hours, stained with PI, and analyzed by flow 
cytometry.  (B) Mouse podocytes were transfected with different ApoL isoforms or GFP and 
treated as in (A).  The graph represents the fold change in the ratio of GFP+/GFP- cells in the live 
cell gate (PI-) after palmitate treatment.  The data represent mean ± SD of 3 independent 
experiments. * p<0.05, ** p<0.01 vs. cells transfected with GFP only.  
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Figure 4. Knockdown of ApoL1  in podocytes increases palmitate-induced cell death 
(A) Western blot of control and ApoL1 knockdown human podocytes.  β-actin was used as 
loading control.  (B) Control and ApoL1 knockdown podocytes were treated with BSA or 500 
µM fatty acids as indicated for 24 hours.  Graph represents percent of Annexin V+/7AAD+ cells.  
The data represent mean ± SD of mutiple experiments. ** p<0.01    
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Figure 5. ApoL1 G1 and G2 variants reduce lipotoxicity in podocyte to a similar degree 
compared to wild-type ApoL1 
Mouse podocytes were transfected with wild-type or G1/G2 variants of ApoL1.  24 hours after 
transfection, the cells were treated with 250 µM palmitate for 24 hours and stained with PI.  The 
graph represents the fold change in the ratio of GFP+/GFP- cells in the live cell gate (PI-) after 
palmitate treatment.  
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CHAPTER III 
Role of NKG2D in Obesity-induced Adipose Tissue Inflammation  
and Insulin Resistance 
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INTRODUCTION 
 
Obesity has become a serious health issue worldwide.  A key metabolic feature that 
commonly accompanies obesity is insulin resistance, which refers to an inadequate response by 
insulin target tissues to the physiologic effects of circulating insulin.  The major functions of 
insulin include stimulation of glucose uptake in skeletal muscle, inhibition of hepatic glucose 
production, and suppression of lipolysis in adipose tissue.  Insulin resistance is a serious health 
concern because it increases the likelihood of developing type 2 diabetes and other metabolic 
disorders, including hypertension, nonalcoholic fatty liver disease, and cardiovascular diseases 
(Kahn et al. 2006).  
Recent studies have pointed to chronic inflammation in insulin target tissues as one of 
the causal links between obesity and insulin resistance (Gregor and Hotamisligil 2011; Osborn 
and Olefsky 2012; Odegaard and Chawla 2013).  Multiple inflammatory cytokines (TNF-, IL-
6, etc.) and signaling pathways (JNK, NF-κB) have been implicated in obesity-induced insulin 
resistance (Hotamisligil et al. 1993; Barnes and Karin 1997; Karin et al. 1997; Yuan et al. 2001; 
Hirosumi et al. 2002; Cai et al. 2005; pArkan et al. 2005). 
The adipose tissue plays a key role in regulating systemic metabolism.  In addition to 
being a storage depot for lipids, the adipose tissue secrets a number of paracrine and endocrine 
factors, known as adipocytokines, that modulate metabolism and inflammation in the liver and 
muscle and pancreatic islets (Ouchi et al. 2011).  In obese mice, the secretion profile of the 
adipose tissue is altered by the pro-inflammatory milieu.  Secretion of pro-inflammatory 
adipocytokines, such as resistin, IL-6, and TNF-, is increased while anti-inflammatory and 
insulin-sensitizing adipocytokines like adiponectin are down-regulated.  Therefore it is thought 
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that dysregulation of the adipose tissue induces insulin-resistance and inflammation in major 
metabolic tissues during obesity. 
Despite much effort, the initiating events that cause inflammation in obese adipose tissue 
are yet to be clearly understood.  Hypoxia and ER stress have been shown to activate 
inflammatory signaling pathways in obese adipose tissue, but it is unclear whether they are the 
primary switch that triggers inflammation (Ozcan et al. 2004; Ozcan et al. 2006; Hosogai et al. 
2007; Ye et al. 2007; Yoshiuchi et al. 2008).      
Various immune cell types have been implicated in obesity-induced insulin resistance 
(Mathis 2013).  Among them, macrophages are considered to be the major mediators of adipose 
tissue inflammation (Olefsky and Glass 2010; Chawla et al. 2011).  Macrophages can constitute 
up to ~40% of the cell number in the adipose tissue during obesity are responsible for the 
majority of Tnfa expression in the adipose tissue (Weisberg et al. 2003; Xu et al. 2003).  
Additionally, in contrast to the resident macrophages found in the adipose tissue of lean mice, 
the macrophages recruited to the adipose tissue during obesity are pro-inflammatory (Lumeng et 
al. 2007).  The resident macrophages display characteristics of “alternatively activated” or M2 
macrophages and express anti-inflammatory cytokines such as IL-10, while the newly infiltrating 
macrophages are of the “classically activated” or M1 category and express high levels of TNF- 
and iNOS (Lumeng et al. 2007; Martinez et al. 2008). 
More recently, T cells have emerged as a key component in obesity-induced adipose 
tissue inflammation.  Multiple studies have reported increased numbers of CD8 T cells in the 
adipose tissue of obese rodents and humans along with elevated levels of IFN- and RANTES, 
which are important for T cell function and recruitment (Caspar-Bauguil et al. 2005; Wu et al. 
2007; Kintscher et al. 2008; Rausch et al. 2008; Rocha et al. 2008; Duffaut et al. 2009).  
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Interestingly, accumulation of T cells prior to infiltration of macrophages and the onset of insulin 
resistance, giving rise to the idea that recruitment of pro-inflammatory T cells could be a primary 
event that initiates adipose tissue inflammation (Kintscher et al. 2008; Duffaut et al. 2009).  
More detailed studies of the different T cell subsets have shown that the number of regulatory T 
cells (Treg cells), which occupy the adipose tissue of lean mice and restrict inflammation, 
decreases during the progression of obesity (Feuerer et al. 2009; Winer et al. 2009; Deiuliis et al. 
2011).  Meanwhile, CD8 and TH1 CD4 cell numbers are increased in the obese adipose tissue, 
and depletion of CD8+ cells alleviated adipose tissue inflammation and insulin resistance in 
obese mice (Nishimura et al. 2009; Winer et al. 2009; Yang et al. 2010).  Together, these studies 
describe a situation during the onset of obesity where CD8+ and TH1 CD4+ cells overwhelm the 
immune-regulatory function of Treg cells, leading to subsequent infiltration of macrophages and 
chronic inflammation in the adipose tissue.   
Still, the question of what initiates the infiltration and activation of adipose tissue T cells 
remains to be answered.  It has been suggested that T cells are responding to chemokines and 
cytokines produced in the adipose tissue in response to cell death or hypoxia (Cinti et al. 2005; 
Rausch et al. 2008; Feuerer et al. 2009).  A more provocative idea is that certain antigens 
produced in the adipose tissue under obese conditions could direct immune cell responses.  This 
hypothesis is supported by the observation that adipose tissue T cells express a restricted 
repertoire of T cell receptors (TCRs), whose profile is unique from that of T cells in the spleen or 
lymph nodes (Feuerer et al. 2009; Winer et al. 2009; Yang et al. 2010).  Though intriguing and 
novel, these models require further investigation to be validated. 
 An alternative way of T cell recruitment and accumulation in tissues is through the 
interaction between certain high affinity receptors and their ligands independent of antigen.  Our 
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lab has previously shown that NKG2D (natural-killer group 2, member D), a cell surface 
receptor expressed in cytotoxic T lymphocytes (CTLs), is sufficient to induce recruitment of 
CTLs to pancreatic islets over-expressing its ligand and cause insulitis (Markiewicz et al. 2012).  
NKG2D is a stimulatory receptor expressed in NK cells, CD8+ T cells,  T cells, and 
macrophages (Raulet 2003).  Engagement of murine NKG2D by one of its various ligands is 
sufficient to fully activate NK cells and macrophages, while in CD8+ T cells, it functions 
primarily as a co-stimulatory receptor that amplifies TCR signaling (Groh et al. 2001; Jamieson 
et al. 2002; Markiewicz et al. 2005).  NKG2D has been shown to be involved in various immune 
responses, such as viral immunity, tumor surveillance, and autoimmune diseases, and its 
importance is underlined by the various ways viruses and tumors have evolved to evade 
recognition by NKG2D (Burgess et al. 2008; Van Belle and von Herrath 2009). 
 NKG2D binds to a number of distinct ligands that share structural homology with MHC 
class-I proteins with high affinities (nanomolar to low micromolar range) (Raulet 2003).  The list 
of NKG2D ligands include two MHC class-I polypeptide-related chain (MIC) proteins and six 
cytomegalovirus UL16-binding proteins (ULBP) in human and five retinoic acid early transcript 
(RAE) proteins, three histocompatibility 60 (H60) proteins, and ULBP-like transcript 1 
(MULT1) in mice.  The NKG2D ligands are usually not expressed in normal adult tissues, but 
are up-regulated in response to various ‘cellular stress conditions’, such as oxidative stress, viral 
infection, and DNA damage (Samarakoon et al. 2009).  The induced ligands are thought to act as 
a signal to the immune system for the removal of damaged cells.      
The adipose tissue and other major metabolic tissues of obese mice and humans are characterized 
by numerous stress conditions, such as nutrient stress (from elevated glucose and lipid levels), 
ER stress, oxidative stress, hypoxia, and chronic inflammation (Hotamisligil 2006; Ye 2009).  
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Some of these stress stimuli overlap with conditions previously shown to up-regulate NKG2D 
ligand expression.  In fact, the human NKG2D ligands MICA and MICB have been shown to be 
induced in the liver of obese patients (Kahraman et al. 2010).  This leads to an interesting 
hypothetical model in which the stress-inducing environment of the adipose tissue during obesity 
could cause the induction of NKG2D ligand expression and recruitment of CD8+ T cells.  This 
study was designed to test the validity of this model and determine the possible role of NKG2D 
in obesity-induced insulin resistance. 
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MATERIALS AND METHODS 
 
Cell Culture 
 3T3-L1 fibroblasts (from American Tissue Type Culture Collection) were maintained and 
differentiated as previously described (Song et al. 2008).  For NKG2D ligand expression 
experiments, differentiated 3T3-L1 cells (day 7, ~95% differentiated) were treated with 5 µg/ml 
insulin (Sigma), 50 ng/ml TNF-α (Peprotech, Rocky Hill, NJ), 3 µg/ml tunicamycin (EMD 
Millipore, Darmstadt, Germany), 50mU/ml glucose oxidase (Sigma), 100 ng/ml LPS (Invivogen, 
San Diego, CA), and 500 µM palmitate (Nu-Chek Prep) conjugated to 250 µM fatty acid-free 
BSA (SeraCare Life Sciences) for 24 hrs.  
 
Mice 
 All mice were housed in a specific pathogen-free facility at Washington University 
School of Medicine.  C57BL/6J and ob/ob (B6.V-Lepob/J) mice were purchased from The 
Jackson Laboratory.  NKG2D-deficient (Klrk1-/-) mice have been previously described (Zafirova 
et al. 2009).  The PCCALL-Rae1 mice have been previously described (Markiewicz et al. 
2012).  Adiponectin-Cre transgenic mice were provided by Dr. P. Scherer (University of Texas 
Southwestern Medical Center) (Wang et al. 2010).  High-fat diet (HFD) mice were fed a 60 
kcal% fat diet from Research Diets, Inc. (New Brunswick, NJ).  Normal chow control mice were 
fed a diet of 13 kcal% fat from LabDiet (St. Louis, MO).  Care and use of mice were conducted 
in accordance with protocols approved by the Animal Studies Committee at Washington 
University in St. Louis (Protocol Number: 20120013), in compliance with the Animal Welfare 
Act. 
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Real-time Quantiative PCR Analysis 
 RNA was extracted from 3T3-L1 cells, epidydymal fat tissue, or fractionated adipocytes 
and stromal vascular cells with TRIzol (Life Technologies).  RNA was reverse transcribed using 
random primers with the High Capacity cDNA Reverse Transcription Kit (Life Technologies).  
Real-time quantitative PCR was performed using the SYBR Green method on the 7500 Fast 
Real-Time PCR system (Life Technologies).  Transcript levels were normalized to HPRT or -
actin.  
 The sequence of primers were: Rae-1 pan F - CCA CCT GGG AAT TCA ACA TC; Rae-
1 pan R - TGA TCT TGG CTT TTC CTT GG; Mult-1 F - CAA AGG TCT GCT GCT TCA CA; 
Mult-1 R - TGC TTG TGT CAA CAC GGA AT; H60b F - TGC CTC AAC AAA TCG TCA 
TC; H60b R - CAC TCA GAC CCT GGT TGT CA; CD68 F - TAC CCA ATT CAG GGT GGA 
AG; CD68 R - ATG GGT ACC GTC ACA ACC TC; TNF- F - ACG GCA TGG ATC TCA 
AAG AC, TNF- R - AGA TAG CAA ATC GGC TGA CG; MCP-1 F - TCC CAA TGA GTA 
GGC TGG AG; MCP-1 R - TCT GGA CCC ATT CCT TCT TG; adiponectin F - GAC AAG 
GCC GTT CTC TTC AC; adiponectin R - CAG ACT TGG TCT CCC ACC TC; adipsin F - 
AGC GAT GGT ATG ATG TGC AG; adipsin R - ATT GCA AGG GTA GGG GTC TC; -
actin F - GAA GAG CTA TGA GCT GCC TGA; -actin R - GCA CTG TGT TGG CAT AGA 
GGT, HPRT F - ATC AGT CAA CGG GGG ACA TA; HPRT R - AGA GGT CCT TTT CAC 
CAG CA 
 
Fat Tissue Fractionation 
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 The epidydymal fat tissue was isolated from euthanized mice, rinsed in PBS, weighed, 
and minced into small pieces (~1 mm).  The minced tissue was digested in KRH buffer (4.8 mM 
KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 118 mM NaCl, 20 mM HEPES [pH 7.5]) supplemented 
with 1.5% bovine serum albumin (BSA) (SeraCare Life Sciences), 30 μg/ml Liberase TM 
(Roche Applied Science, Indianapolis, IN), and 1 μg/ml DNaseI (Sigma) at 37°C for 25~40 
minutes with vigorous shaking.  The digested samples were strained through a sterile 250 μm 
nylon mesh (Sefar, Buffalo, NY) and centrifuged at 200g for 10 min.  The floating cells were 
collected as the adipocyte fraction and the pelleted cells were collected as the stromal vascular 
fraction (SVF).  The adipocytes were washed twice with KRH buffer + 1.5% BSA before being 
processed for RNA extraction.  The SVF was resuspended in ACK lysis buffer (150 mM NH4Cl, 
10 mM KHCO3, 0.1 mM EDTA) and incubated at room temperature for 2 minutes to deplete 
erythrocytes, washed twice with KRH buffer + 1.5% BSA, and finally resuspended in FACS 
buffer (1% BSA, 2 mM EDTA in 1×PBS) for flow cytometry or processed for RNA extraction. 
 
Isolation of Splenocytes and Peripheral Blood Mononuclear Cells (PBMCs) 
Spleen harvested from euthanized mice were homogenized and filtered through a 40-
micron cell strainer.  The cells were then washed with PBS, depleted of erythrocytes with ACK 
lysis buffer, washed twice with PBS, and resuspended in FACS buffer. 
For PBMCs, whole blood was collected from mice in EDTA-coated vacutainers (BD 
Biosciences).  The blood was mixed with PBS and centrifuged at 300g for 10 minutes.  The cells 
were then resuspended in ACK lysis buffer, washed twice with PBS, and resuspended in FACS 
buffer.  
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Immunofluorescent Staining and Flow Cytometry 
 Single-cell suspensions from the SVF of fat tissue, spleen, and blood samples were 
incubated in FcBlock (BD Biosciences) for 15 min at 4°C.  The cells were then stained with 
fluorophore-conjugated antibodies for 20 min at 4°C in the dark.  The antibodies were purchased 
from BD Biosciences (CD8-FITC, CD11c-FITC, NK1.1-FITC, CD4-PE/Cy7, CD45.2-APC), 
eBioscience (San Diego, CA) (NKG2D-PE, F4/80-PE/Cy7, CD11b-APC/eFluor780), or 
BioLegend (San Diego, CA) (CD3-Pacific Blue).  Dead cells were excluded with 7-AAD 
staining (BD Biosciences).  Flow cytometry data was acquired with FACSCantoII or LSRII flow 
cytometer (BD Biosciences) and analyzed with FlowJo (Treestar). 
 
Metabolic Studies 
Male mice were placed on a HFD beginning at 8 weeks of age, and body weight was 
monitored weekly.  Mice were fasted overnight (12 h) prior to measuring fasting blood glucose 
or performing glucose tolerance tests (GTT) and insulin tolerance tests (ITT).  For GTT, glucose 
(1 g/kg in saline) was administered by intraperitoneal (i.p.) injection. Blood glucose levels were 
measured before and 15, 30, 60, 120 min after glucose injection with a handheld ContourTS 
glucometer (Bayer, Tarrytown, NY).  For ITT, insulin (0.75 U/kg, Humulin R, Lilly, 
Indianapolis, IN) was administered by i.p. injection and blood glucose levels were measured 
before and 15, 30, 60, 120 min after insulin injection. 
 
CTL Adoptive Transfer 
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CTL adoptive transfer experiments were performed as described previously (Markiewicz 
et al. 2012).  Briefly, CTLs were generated in vitro by culturing splenocytes and lymph node 
cells from OT-1 T cell receptor transgenic mice in IMDM + 10% FCS with 1 μM OVA peptide 
(SIINFEKL) (provided by Dr. P. Allen, Washington University School of Medicine) for 5 days.  
Live cells were harvested using Ficoll-hypaque (GE Healthcare, Piscataway, NJ) and labeled 
with 1 μM CFSE (Invitrogen) and injected intravenously (107 cells/mouse).  Epididymal adipose 
tissue and spleen were harvested 24 hours after injection and processed for flow cytometry. 
 
Statistical analyses 
Data were routinely presented as mean +/- standard deviation (SD).  We determined 
significance by the Student's t test or ANOVA.  We considered a P value of < 0.05 as statistically 
significant. 
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RESULTS 
 
Induction of NKG2D ligands in fat tissue of obese mice 
 NKG2D binds to a number of distinct ligands which are usually not expressed in normal 
adult tissues, but are up-regulated in response to various ‘cellular stress conditions’, such as 
oxidative stress, viral infection, and DNA damage (Samarakoon et al. 2009).  The induced 
ligands are thought to act as a signal to the immune system for the removal of damaged cells.  In 
order to identify factors that could potentially regulate NKG2D ligands in adipocytes, we 
incubated differentiated 3T3-L1 cells with factors that induce various cell responses.  Insulin and 
TNF- treatment caused a significant increase in the mRNA levels of different NKG2D ligands 
at varying concentrations.  Insulin had the greatest effect on Rae-1 mRNA level among the 
NKG2D ligands (Fig. 1a) while TNF- treatment increased both Rae-1 and Mult-1 (Fig. 1a and 
b).  H60b mRNA levels were only moderately affected by insulin and TNF- (Fig. 1c).  
Meanwhile, incubation in tunicamycin, glucose oxidase, LPS, and palmitate did not have an 
effect (Fig. 1d).  
 Insulin and TNF- levels are known to be elevated during obesity in humans and rodents.  
To address whether NKG2D ligands are induced by obesity, we analyzed the adipose tissue of 
diet-induced obese (DIO) mice.  RNA was isolated from epididymal adipose tissue obtained 
from mice fed either a normal diet (ND) or a high-fat diet (HFD) and analyzed by real-time 
qPCR.  Rae-1 and Mult-1 mRNA levels were increased approximately 5-fold and 17-fold 
respectively in the DIO mice compared to lean control mice (Fig. 2a).  H60b expression level 
was not altered in DIO mice.  As control, we confirmed increased expression of CD68, TNF-, 
and MCP-1 and decreased expression of adiponectin and adipsin in DIO mice (Fig. 2b). 
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 To confirm these results, we also analyzed the adipose tissue of ob/ob mice, a genetic 
model of obesity (Fig. 2c, d).  Similar to the DIO mice, Rae-1 and Mult-1 transcript levels were 
increased in the ob/ob mice compared to lean ob/+ controls (Fig. 2c).  In addition, H60b mRNA 
level was also slightly increased in the ob/ob mice (Fig. 2c).  
 The adipose tissue is composed of adipocytes, immune cells, vascular cells, and 
undifferentiated preadipocytes.  In order to determine which cell types express NKG2D ligands, 
the adipose tissue was fractionated into adipocytes and the stromal vascular fraction (SVF) via 
collagenase digestion.  Rae-1 was expressed predominantly in the adipocyte fraction while Mult-
1 had similar expression levels in the adipocytes and the SVF (Fig. 3a).  H60b expression was 
higher in the adipocyte fraction (Fig. 3a). 
 Induction of NKG2D ligands in the adipose tissue of obese mice led us to hypothesize 
that this could be a mechanism by which CD8 T cells are recruited to the adipose tissue to 
initiate inflammation during obesity.  Infiltration of CD8 T cells to the adipose tissue of DIO 
mice has been shown to occur relatively soon after starting the HFD regimen (4~5 weeks after 
initiation of diet).  In order to see whether NKG2D ligand induction occurs within a similar time 
frame, we measured the time-course kinetics of NKG2D ligand expression in DIO mice (Fig. 
3b).  The mRNA levels of Rae-1 and Mult-1 were highest at the earliest time-point measured (3 
weeks post-initiation of diet) and gradually decreased during the progression of obesity.  These 
results suggest that early changes that occur in the adipose tissue of mice on a HFD induce 
expression of NKG2D ligands. 
 
Obesity-induced insulin resistance and adipose tissue inflammation in NKG2D-deficient mice 
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 The NKG2D–deficient (klrk-/-) mice lack expression of NKG2D in all immune cells 
including CD8 T cells.  To directly test whether NKG2D ligands are involved in the 
development of obesity-induced insulin resistance, we placed wild-type and klrk-/- mice on a 
HFD.  Age-matched male mice were divided into two groups and placed on either ND or HFD.  
We measured the changes in body weight and fasting glucose levels for 18 weeks.  In order to 
measure insulin sensitivity, we performed glucose tolerance test (GTT) and insulin tolerance test 
(ITT) at 6, 12, and 18 weeks after starting the diet regimen. 
 At baseline (8-weeks old), there was no difference between WT and klrk-/- mice in body 
weight (Fig. 4a) and fasting blood glucose levels (Fig. 4b).  Rapidly within a few weeks, mice on 
the HFD began to outweigh mice on the normal diet, and the gap between the two groups 
continued to grow until the end of the experiment.  There was no difference in body weight 
change between WT and klrk-/- mice in either the ND or HFD group throughout the experiment. 
In GTT experiments (Fig. 5a), obese mice were significantly less tolerant compared to 
lean mice in both WT and klrk-/- mice.  However, there was no difference between WT and klrk-/- 
mice in any of the time points.  Similar results were obtained in ITT assays (Fig. 5b) with WT 
and klrk-/- mice displaying similar degrees of insulin sensitivity.  Fasting glucose, which is also 
indicative of insulin sensitivity, was not altered in klrk-/- mice (Fig. 4b). 
At the end of 18 weeks on the diet regimen, the epididymal adipose tissue was harvested 
to analyze immune cell infiltration.  The SVF was isolated by collagenase digestion, stained for 
cell surface markers, and analyzed by flow cytometry.  Consistent with previous reports, there 
was a significant increase in the number of F4/80+CD11c+ M1 macrophages and CD8 T cells in 
the adipose tissue of HFD-fed mice compared to lean counterparts (Fig. 6b).  However, the 
number of M1 macrophages and CD8 T cells in the adipose tissue were similar in WT and klrk-/- 
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mice (Fig. 6a, d).  We also confirmed that there was no difference in CD8 T cell infiltration after 
3 weeks of HFD, when NKG2D ligand expression was highest (data not shown).  These results 
indicate that NKG2D does not affect CD8 T cell recruitment to the adipose tissue during obesity. 
 
Obesity-induced adipose tissue inflammation in fat-specific Rae-1 transgenic mice 
In order to confirm these results, we generated a transgenic mice specifically over-
expressing Rae-1ε in the adipose tissue (AdpnCre+ Rae+) by crossing adiponectin-Cre mice 
(Wang et al. 2010) with PCCALL-Rae1 mice (Markiewicz et al. 2012).  Real-time qPCR was 
used to confirm Rae-1ε over-expression in the adipose tissue (Fig. 7a).  Rae-1 mRNA levels 
were not altered in liver and muscle (data not shown), indicating specific overexpression of Rae-
1 in the adipose tissue.  It is known that NKG2D expression in NK cells and T cells is down-
regulated in transgenic mice constitutively overexpressing NKG2D ligands (Oppenheim et al. 
2005; Wiemann et al. 2005).  Indeed, we observed loss of NKG2D expression in NK cells 
isolated from the adipose tissue, but not spleen or blood, again confirming fat-specific 
overexpression of Rae-1 in the Adpn+ Rae+ mice (Fig. 7b). 
To examine the early events of obesity-induced immune cell infiltration, these transgenic 
mice (AdpnCre+ Rae+) were placed on a high-fat diet for 5 weeks along with their littermate 
controls (AdpnCre+ Rae-).  At the end of 5 weeks, the SVF from the adipose tissue were 
analyzed by flow cytometry.  Adipose tissue from obese mice contained approximately twice 
the number of M1 macrophages and CD8 T cells compared to lean mice (Fig. 8a, d).  However, 
the number of CD8 T cells and M1 macrophages in the adipose tissue was not altered by fat-
specific overexpression of Rae-1ε (Fig. 8a, d).  These results are consistent with the observations 
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made in klrk-/- mice and confirm that NKG2D is not involved in the recruitment of CD8 T cells 
to the adipose tissue during obesity.  
The klrk-/- mice and AdpnCre+ Rae+ mice used in the previous experiments were housed 
in specific pathogen-free (SPF) conditions, and therefore the number of circulating CTLs is 
minimal.  In mice, NKG2D is expressed in activated CTLs, but not in naïve CD8 T cells.  We 
therefore speculated that the lack of a phenotype could be due to low numbers of circulating 
CTLs.  In addition, it was possible that the constitutive overexpression of Rae-1 was down-
regulating NKG2D expression in circulating T cells.  To circumvent these issues, and to directly 
test whether up-regulation of NKG2D ligands can induce recruitment and accumulation of 
cytotoxic CD8 T cells in the adipose tissue, we intravenously injected CFSE-labeled CTLs into 
control and AdpnCre+ Rae+ mice.  24 hours after injection, we measured the number of CFSE+ 
CTLs recruited to the spleen and adipose tissue (Fig. 9).  Similar numbers of CFSE+ CTLs were 
detected in the spleen of AdpnCre+ Rae- and AdpnCre+ Rae+ mice, indicating that equal number 
of CTLs was successfully transferred to each mice.  In the adipose tissue, overexpression of Rae-
1 did not result in increased recruitment of CTLs.  These results demonstrate that, in contrast to 
pancreatic islets, NKG2D-NKG2D ligand interaction is not sufficient to drive accumulation of 
NKG2D-expressing CTLs in the adipose tissue. 
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DISCUSSION 
 
 In this study, we tested a model of antigen-independent recruitment of CD8+ T cells to 
the adipose tissue during obesity via NKG2D-NKG2D ligand engagement.  Results from our 
experiments suggest that interaction between the immunoreceptor NKG2D and its cognate 
ligands is not critically involved in the development of adipose tissue inflammation during diet-
induced obesity.  Neither deletion of NKG2D nor fat-specific overexpression of an NKG2D 
ligand had significant effects on insulin sensitivity or infiltration of immune cells to the adipose 
tissue in the setting of a high-fat diet.   
 This lack of phenotype does not seem to be due to strain-specificity of the mice used in 
our experiments.  The composition of immune cells is known to vary among different strains of 
mice (Petkova et al. 2008).  In addition, the immune system is compromised in certain genetic 
obese mice models, such as the ob/ob mice or the db/db mice, because leptin is required for 
immune cell homeostasis, especially T cells (Lam and Lu 2007).  In order to avoid such 
variables, we chose to utilize the diet-induced obese (DIO) mouse model using C57BL/6 mice.  
The C57BL/6 strain is the predominant strain used to study nutrient-dependent metabolic 
disorders in the literature and was the strain used to demonstrate the involvement of various 
immune cells in obesity-induced inflammation.   
The NKG2D-deficient mice display a NK cell hyperproliferation phenotype (Zafirova et 
al. 2009), which could be a confounding factor in the case that NK cells are also involved in 
adipose tissue inflammation.  However, as of date, NK cells have not been clearly implicated in 
obesity-induced insulin resistance.  There have been conflicting reports of changes in the number 
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of NK cells in the adipose tissue during obesity.  In our experiments, we did not observe a clear 
reproducible pattern of NK cell recruitment.   
Similar to the NKG2D-deficient mice, we did not observe any difference in immune cell 
infiltration in the fat-specific Rae-1ɛ mice.  We could not directly determine the protein level of 
Rae-1ɛ in the adipocytes of the fat-specific Rae-1ε mice due to the lack of antibodies suitable for 
immunohistochemistry or Western blots and the technical difficulties in performing flow 
cytometry with adipocytes.  However, we did observe a nearly complete down-regulation of 
NKG2D specifically in NK cells isolated from the adipose tissue, but not in cells isolated from 
spleen or blood.  It is well known that engagement of Rae1ɛ by NKG2D results in NKG2D 
down-regulation (Groh et al. 2002; Ogasawara et al. 2003; Oppenheim et al. 2005).  Therefore, 
these results show that the level of transgene expression was sufficient to completely quench 
NKG2D expression on NK cells in the adipose tissue, suggesting that Rae-1ɛ is being expressed 
at biologically relevant levels. 
Although we observed induction of both Rae-1 and Mult-1 in obese mice, only Rae-1 
was expressed specifically in fat cells.  As adiponectin-Cre mice induce transgene expression 
only in fat cells and not in stromal vascular cells, we speculated that overexpressing Rae-1ε 
would closely resemble the expression pattern of NKG2D ligands during obesity.  However, it is 
possible that overexpressing Mult-1 instead could have yielded different results.  
It has been shown that circulating levels of CD8+ T cells in male C57BL/6 mice are 
relatively low compared to other mouse strains.  In addition, NKG2D is only expressed in 
activated CD8+ T cells, the number of which may not be sufficient in mice raised in a SPF 
facility.  In order to circumvent these issues, we adoptively transferred activated CTLs into the 
fat-specific Rae-1ɛ transgenic mice.  Contrary to our expectations, overexpression of Rae-1ɛ in 
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adipocytes did not lead to accumulation of CTLs in the adipose tissue.  This is in contrast to 
previous results from similar experiments performed in the pancreatic islets (Markiewicz et al. 
2012).  This may be due to differences in the architecture of the vasculature between the 
pancreas and the adipose tissue, which could affect how surface proteins are detected by 
lymphocytes in circulation. 
  Despite the lack of evidence for the involvement of NKG2D in obesity-induced 
inflammation and insulin resistance, it is still interesting that NKG2D ligands are up-regulated in 
the adipose tissue in response to a high fat diet.  In fact, the human NKG2D ligands MICA and 
MICB have been shown to be induced in the liver of obese patients (Kahraman et al. 2010).  In 
addition, NKG2D ligands are induced in the aorta of ApoE-/- mice fed a western diet and are 
involved in atherosclerotic plaque formation (Xia et al.).  The nature of the response of the 
immune system to NKG2D ligand induction necessitates a tight regulation of its expression.  
Previous studies have shown that various ‘cell stress’ conditions, including DNA damage and 
viral infection, can induce NKG2D ligand expression.  However, it seems that such cues are not 
sufficient to up-regulate NKG2D ligands in all cell types.  It is more likely that different signals 
trigger the expression of the multiple NKG2D ligands in different cell types.  Indeed, insulin and 
TNF-α was able to significantly increase transcript levels of Rae-1 and Mult-1, but not H60b, in 
differentiated 3T3-L1 adipocytes.  Notably, high-fat diet resulted in the up-regulation of the 
same subgroup of NKG2D ligands, namely Rae-1 and Mult-1.  Therefore, it is tempting to 
speculate that these signals are also responsible for the induction of NKG2D ligands in the 
adipose tissue in vivo given that insulin and TNF-α levels are known to be elevated in obesity.   
Interestingly, multiple NKG2D ligands were expressed in undifferentiated 3T3-L1 cells 
and the expression levels decreased after differentiation (data not shown).  This could be 
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attributed to the cease of proliferation that occurs when 3T3-L1 cells differentiate.  It was 
recently demonstrated that Rae-1 expression is regulated by the transcription factor E2F, which 
is associated with cell cycle.  On the other hand, it is also possible that NKG2D ligand 
expression is actively repressed by the differentiation process.  Identification of such factors 
would shed light on how the strict regulation of NKG2D ligands is achieved in various cell 
types.  
 The biological significance of NKG2D ligand induction in the adipose tissue during 
obesity is unclear.  Adipocytes in the adipose tissue of HFD-fed mice are subjected to various 
cell stress conditions due to increased metabolic loads, hypoxic conditions, and proinflammatory 
environment.  Hence, the most obvious explanation would be that NKG2D ligands are being 
expressed by damaged adipocytes.  It should be noted that the different types of NKG2D ligands 
do not seem to respond in the same manner.  Only Rae-1 and Mult-1 were induced by the 
introduction of the high-fat diet while H60b levels remained the same.  Furthermore, Rae-1 was 
predominantly found in adipocytes whereas Mult-1 expression levels were similar in adipocytes 
and stromal vascular cells.  How these differences affect adipose tissue homeostasis and/or 
pathology during obesity remain to be determined. 
 In summary, our results rule out the interaction between NKG2D and its ligands as a 
possible mechanism of CD8+ T cell recruitment to the adipose tissue during obesity.  Our 
findings regarding the induction of NKG2D ligands in the adipose tissue during obesity provide 
a new model to investigate the mechanisms involved in the regulation of NKG2D ligand 
expression. 
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Figure 1.  Insulin and TNF- increases NKG2D ligand expression in 3T3-L1 adipocytes. 
(A-C) Differentiated 3T3-L1 cells were treated with insulin (0.5 - 5 μg/ml) or TNF- (10 - 100 
ng/ml) for 24 hours.  The cells were then analyzed by quantitative PCR to determine the 
expression levels of (A) Rae-1, (B) Mult-1, and (C) H60b.  (D) Differentiated 3T3-L1 cells were 
treated with insulin, TNF-, tunicamycin, glucose oxidase, LPS, and palmitate.  The cells were 
then analyzed by quantitative PCR for NKG2D ligand expression.  The results were normalized 
to HPRT levels and are shown as fold-increase over control.  The data represent mean  SD of 3 
independent experiments. * p<0.05, ** p<0.01 vs. control 
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Figure 2.  NKG2D ligands are increased in the adipose tissue of obese mice. 
Expression of NKG2D ligands in the epididymal adipose tissue from (A) DIO mice (8 weeks on 
HFD) and (C) ob/ob mice was determined by quantitative PCR.  mRNA levels of CD68, TNF-, 
MCP-1, adiponectin, and adipsin were measured in (B) DIO mice and (D) ob/ob mice for 
control.  The results were normalized to HPRT levels and are shown as fold-increase over lean 
control mice.  The data represent mean  SD of 3 independent experiments. * p<0.05, ** p<0.01 
vs. lean control mice. 
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Figure 3.  NKG2D ligands are increased in the adipocytes of obese mice. 
(A) The epididymal adipose tissue of DIO mice was fractionated into the stromal vascular 
fraction and adipocytes and analyzed by quantitative PCR for expression of NKG2D ligands.  
(B) Adipocytes were obtained from the epipdidymal adipose tissue of DIO mice at different time 
points after starting high-fat diet.  The adipocytes were then analyzed by quantitative PCR for 
expression of NKG2D ligands.  The results were normalized to -actin levels and are shown as 
fold over (A) stromal vascular fraction or (B) lean control mice.  The data represent mean  SD 
of 3 independent experiments. * p<0.05, ** p<0.01 vs. (A) stromal vascular fraction or (B) lean 
control mice. 
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Figure 4.  Body weight gain and fasting glucose levels are not altered in klrk-/- mice.   
(A) Body weight of WT and klrk-/- mice placed on normal diet or high-fat diet for 18 weeks.  (B) 
Fasting blood glucose levels measured after 0, 6, 12, and 18 weeks on high-fat diet.   
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Figure 5.  Susceptibility to obesity-induced insulin resistance is not altered in klrk-/- mice.   
(A) Glucose tolerance test and (B) insulin tolerance tests were performed after 0, 6, 12, and 18 
weeks on high-fat diet.  The numbers of mice used for each experiment were at least 10 for WT 
normal diet, at least 9 for WT high-fat diet, at least 16 for klrk-/- normal diet, and at least 18 for 
klrk-/- high-fat diet. 
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Figure 6.  Immune cell infiltration of adipose tissue during obesity is not altered in klrk-/- 
mice.   
The stromal vascular fraction was isolated from the epididymal adipose tissue of DIO and lean 
mice after 18 weeks on high-fat diet regimen.  The cells were stained with antibodies to identify 
(A) M2 macrophages (F4/80+, CD11c-), (B) M1 macrophages (F4/80+, CD11c+), (C) CD4 T cells 
(CD3+, CD4+), (D) CD8 T cells (CD3+, CD8+), and (E) NK cells (CD3-, NK1.1+) and 
analyzed by flow cytometry. The cells were gated on 7AAD-, CD45+ populations.  The data 
represent mean  SD of 3 independent experiments.  
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Figure 7.  Rae-1 is overexpressed specifically in the adipose tissue of AdpnCre+ Rae+ mice.   
(A) The epididymal adipose tissue from AdpnCre+ Rae+ and control mice were analyzed by 
quantitative PCR to determine Rae-1 expression. The results were normalized to -actin levels 
and are shown as fold-increase over AdpnCre- Rae- mice.  The data represent mean  SD of 3 
independent experiments. ** p<0.01 vs. AdpnCre- Rae- mice.  (B) Splenocytes, peripheral blood 
mononuclear cells (PBMC), and stromal vascular fractions isolated from the epididymal adipose 
tissue of AdpnCre- Rae+ and AdpnCre+ Rae+ mice were stained with NKG2D antibodies and 
analyzed by flow cytometry.  Cells were gated on 7AAD-, CD45+, CD3-, NK1.1+ populations.  
NKG2D is down-regulated only in NK cells isolated from the adipose tissue.  
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Figure 8.  Immune cell infiltration of adipose tissue during obesity is not altered in AdpnCre+ 
Rae+ mice.   
The stromal vascular fraction isolated from the epididymal adipose tissue of AdpnCre+ Rae- and 
AdpnCre+ Rae+ mice after 5 weeks on high-fat diet regimen.  The cells were stained with 
antibodies to identify (A) M2 macrophages (F4/80+, CD11c-), (B) M1 macrophages (F4/80+, 
CD11c+), (C) CD4 T cells (CD3+, CD4+), (D) CD8 T cells (CD3+, CD8+), and (E) NK cells 
(CD3-, NK1.1+) and analyzed by flow cytometry. The cells were gated on 7AAD-, CD45+ 
populations.  The data represent mean  SD of 3 independent experiments.  
 
  
119 
 
 
 
 
 
 
 
  
120 
 
 
 
 
 
 
 
 
 
Figure 9.  Rae-1 overexpression does not induce CTL accumulation in the adipose tissue. 
CTLs generated from OT-1 mice were labeled with CFSE and injected intravenously.  A group 
of mice were injected with PBS for control.  Spleen and epididymal adipose tissue were isolated 
24 hours after injection and analyzed by flow cytometry.  Cells were gated on 7AAD-, CD45+, 
CD3+ populations.  The data are representative of at least 3 individual mice per group.  
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